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ABSTRACT
The purpose of this Ph.D. research was to address the clinical need for synthetic
bioactive materials to heal defects in non-loaded and loaded bone. Hollow hydroxyapatite
(HA) microspheres created in a previous study were evaluated as a carrier for controlled
release of bone morphogenetic protein-2 (BMP2) in bone regeneration. New bone
formation in rat calvarial defects implanted with BMP2-loaded microspheres (43%) was
significantly higher than microspheres without BMP2 (17%) at 6 weeks postimplantation.
Then hollow HA microspheres with a carbonate-substituted composition were prepared
to improve their resorption rate. Hollow HA microspheres with ~12 wt. % of carbonate
showed significantly higher new bone formation (73 ± 8%) and lower residual HA (7 ±
2%) than stoichiometric HA microspheres (59 ± 2% new bone formation; 21 ± 3%
residual HA). The combination of carbonate-substituted hollow HA microspheres and
clinically-safe doses of BMP2 could provide promising implants for healing non-loaded
bone defects. Strong porous scaffolds of bioactive silicate (13-93) glass were designed
with the aid of finite-element modeling, created by robocasting and evaluated for loaded
bone repair. Scaffolds with a porosity gradient to mimic human cortical bone showed a
compressive strength of 88 ± 20 MPa, a flexural strength of 34 ± 5 MPa and the ability to
support bone infiltration in vivo. The addition of a biodegradable polylactic acid (PLA)
layer to the external surface of these scaffolds increased their load-bearing capacity in
four-point bending by 50% and dramatically enhanced their work of fracture, resulting
in a “ductile” mechanical response. These bioactive glassPLA composites, combining
bioactivity, high strength, high work of fracture and an internal architecture conducive to
bone infiltration, could provide optimal implants for structural bone repair.
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SECTION
1. PURPOSE OF THIS DISSERTATION
The purpose of this Ph.D. research was to address the clinical need for synthetic
bioactive materials to heal defects in non-loaded bone and structural (loaded) bone. The
research focused on two areas:
(1) Creation and evaluation of biodegradable hollow hydroxyapatite (HA)
microspheres that could serve as devices for local delivery of therapeutics to enhance
healing of non-loaded bone defects;
(2) Design, creation and evaluation of bioactive silicate glass (13-93) scaffolds
with suitable mechanical properties and internal architecture to heal large (critical-size)
defects in structural bone.
Hydroxyapatite is the main inorganic constituent of human bone. Synthetic HA
has several attractive properties as a scaffold material for bone regeneration. It is
biocompatible, bioactive, and osteoconductive, with a proven ability to support bone
regeneration and to bond to surrounding tissue. Previous studies in our research group
determined the process variables for the preparation of hollow HA microspheres with
controlled characteristics such as surface area, shell thickness and pore size of the shell.
The ability of these hollow HA microspheres to serve as a device for controlled delivery
of proteins such as bovine serum albumin was evaluated. In the present study, the ability
of these hollow HA microspheres to release a potent growth factor, bone morphogenetic
protein-2 (BMP2), and enhance bone healing in rat calvarial defects was studied. While
bone regeneration was significantly improved, the HA microspheres themselves showed
little ability to degrade. Ideally, implants for bone regeneration should degrade (or resorb)
and remodel into bone. A follow-up study was undertaken to develop resorbable hollow
HA microspheres. By modifying the process variables, hollow HA microspheres with the
same geometry as those used previously but with a carbonate-substituted composition
were prepared and evaluated in vitro and in vivo.
There is a need for synthetic biomaterials to heal large defects in structural bone
because the available treatments based on the use of autogenous bone grafts, allografts
and porous metals have limitations. Bioactive glass particles and weak scaffolds have
been used to heal small contained bone defects but the development of bioactive glass
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scaffolds with the requisite mechanical properties and internal architecture to heal large
(critical size) defects in structural bone has been a challenge. Previous studies in our
research group showed the ability to create strong porous bioactive silicate glass (13-93)
scaffolds with a uniform grid-like microstructure using a robotic deposition technique.
The scaffolds showed a compressive strength comparable to human cortical bone and a
microstructure conducible to supporting bone infiltration in vivo. However, the flexural
strength of the scaffolds was much lower than human cortical bone. As bending is an
important loading mode in structural bone, a study was undertaken to improve the
flexural strength of the scaffolds. Finite element modeling was used to re-design the
scaffold architecture. Then 13-93 glass scaffolds with the optimal microstructures were
created and evaluated in vitro and in vivo. Scaffolds created with a porosity gradient to
mimic cortical bone showed a nearly 200% increase in flexural strength with no adverse
effect on their compressive strength or ability to regenerate bone. However, the scaffolds
still showed a brittle mechanical response typical of glass. Consequently, the addition of
a biodegradable polymer layer to the external surface of the scaffold was studied as an
approach to modify the brittle mechanical response of the glass scaffold. Composites
formed from 13-93 glass scaffolds and adherent surface layers of polylactic acid (PLA)
of varying thickness were created and tested to study their mechanical response in fourpoint bending.
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I. Hollow hydroxyapatite microspheres: A novel bioactive and osteoconductive
carrier for controlled release of bone morphogenetic protein-2 in bone regeneration
Wei Xiao a, Hailuo Fu a, Mohamed N. Rahaman a, Yongxing Liu a, B. Sonny Bal b
a

Department of Materials Science and Engineering, Missouri University of Science and

Technology, Rolla, MO 65409, USA
b

Department of Orthopaedic Surgery, University of Missouri, Columbia, MO 65212,

USA
ABSTRACT
The regeneration of large bone defects is a common and significant clinical
problem. Limitations associated with existing treatments such as autologous bone grafts
and allografts have increased the need for synthetic bone graft substitutes. The objective
of this study was to evaluate the capacity of novel hollow hydroxyapatite (HA)
microspheres to serve as a carrier for controlled release of bone morphogenetic-2 (BMP2)
in bone regeneration. Hollow HA microspheres (106−150 µm) with a high surface area
(>100 m2 g−1) and a mesoporous shell wall (pore size 10−20 nm) were created using a
glass conversion technique. The release of BMP2 from the microspheres into a medium
composed of diluted fetal bovine serum in vitro was slow, but it occurred continuously
for over 2 weeks. When implanted in rat calvarial defects for 3 or 6 weeks, the
microspheres loaded with BMP2 (1 µg per defect) showed a significantly better capacity
to regenerate bone than those without BMP2. The amount of new bone in the defects
implanted with the BMP2-loaded microspheres was 40% and 43%, respectively, at 3 and
6 weeks, compared to 13% and 17%, respectively, for the microspheres without BMP2.
Coating the BMP2-loaded microspheres with a biodegradable polymer, poly(lactic-coglycolic acid), reduced the amount of BMP2 released in vitro and, above a certain coating
thickness, significantly reduced bone regeneration in vivo. The results indicate that these
hollow HA microspheres could provide a bioactive and osteoconductive carrier for
growth factors in bone regeneration.

4
1. Introduction
The regeneration of large bone defects resulting from trauma, malignancy or
congenital diseases represents a common and significant clinical problem [1]. Autologous
bone grafts are the gold standard for treatment because they possess all the ideal
characteristics for bone growth: osteoconductivity, osteoinductivity and osteogenicity
[1−3]. However, autografts suffer from problems such as donor site morbidity and limited
supply [4−6]. Bone allografts are alternatives, but they are expensive and carry the risk of
disease transmission and adverse host immune reaction. These problems associated with
autografts and allografts have increased the need for synthetic bone graft substitutes.
A variety of synthetic bone graft substitutes have been developed over the last 30
years, including hydroxyapatite (HA), betatricalcium phosphate (β-TCP), biphasic
calcium phosphate (BCP), calcium phosphate cements, bioactive glass and biodegradable
polymers [1−3]. However, synthetic bone graft substitutes currently see limited use
clinically because of their inferior in vivo performance when compared to autogeneous
bone grafts [3]. Most synthetic bone grafts have a limited capacity to reconstitute bone in
large defects because they lack the osteoinductivity and osteogenicity of autologous bone
grafts.
The osteoinductive properties of bone morphogenetic proteins (BMPs) have been
evaluated extensively both in vitro and in vivo [7,8]. Among the recombinant proteins,
BMP2 and BMP7 have been tested in a number of orthopedic and dental applications,
and they are now used clinically. Because direct injection of a growth factor in soluble
form into a defect site is generally not effective for bone regeneration due to rapid
diffusion away from the site, delivery is often provided through a carrier material. A wide
range of materials in various forms such as particles, granules, sponges and porous threedimensional (3-D) scaffolds have been tested as carriers for BMPs. They include
biodegradable polymers, natural and synthetic, such as collagen and poly(lactic-coglycolic acid) (PLGA), hydrogels and calcium phosphates such as HA and betatricalcium phosphate (β-TCP), as well as composites of these materials [8,9].
In the last few years, we have investigated the development of a hollow HA
microsphere technology to meet the need for bone graft substitutes that could approach
the combined osteoconductive, osteoinductive and osteointegrative properties of
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autologous bone grafts. Hollow HA microspheres prepared by a novel glass conversion
technique [10,11] have a high surface area (>100 m2 g−1) and a mesoporous shell wall
(pore size = 10−20 nm) composed of nanocrystalline HA particles [12]. The hollow core
and the mesopores can provide reservoirs for loading growth factors into the
microspheres, while the shell wall can provide methods for controlled release by
desorption and migration of the protein through the mesopores.
Our previous work showed that the hollow HA microspheres can be loaded with
bovine serum albumin (BSA), used as a model protein, and that the microspheres could
function as a carrier for controlled delivery of BSA into phosphate-buffered saline (PBS)
or a poly(ethylene glycol) (PEG) hydrogel in vitro [13,14]. Our more recent work showed
that loading the hollow HA microspheres with transforming growth factor beta 1 (TGFβ1)
(5 µg per defect) can enhance bone regeneration in rat calvarial defects at 6 weeks but not
at 12 weeks [15]. However, the amount of new bone formed in the defects implanted with
the TGF-loaded microspheres was only ~20% of the total defect area after 6 or 12 weeks.
The objective of this study was to evaluate the capacity of the hollow HA
microspheres to serve as a carrier for BMP2 in the regeneration of bone in an osseous
defect model. BMP2 was used in the present study because of its more potent ability to
stimulate bone formation when compared to TGFβ1 [16,17]. The use of a biodegradable
polymer coating to modify the release of BMP2 from the microspheres was studied in
vitro. Bone regeneration in rat calvarial defects implanted with the BMP2-loaded hollow
HA microspheres was evaluated using histomorphometric techniques. The rat calvarial
defect model was used because it is a standard inexpensive assay for evaluating new bone
formation in an osseous defect [18].
2. Materials and methods
2.1. Preparation and characterization of hollow HA microspheres
Hollow HA microspheres were prepared by reacting solid glass microspheres in
an aqueous phosphate solution as described in detail in our previous study [12]. Briefly,
borate glass with the composition 15CaO, 11Li2O, 74B2O3 (wt.%), designated CaLB3-15,
was prepared by melting reagent grade CaCO3, Li2CO3 and H3BO3 (Alfa Aesar, Haverhill,
MA, USA) in a Pt crucible at 1200 oC for 45 min, and quenching the melt between cold
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stainless steel plates. Particles of size 106−150 lm were obtained by grinding the glass in
a hardened steel mortar and pestle, and sieving through 100 and 140 mesh sieves. Glass
microspheres were obtained by dropping the crushed particles down a vertical tube
furnace at 1000 oC [19]. Hollow HA microspheres were obtained by reacting the solid
glass microspheres for 2 days in 0.02 M K2HPO4 solution at 37 oC and a starting pH =
9.0. In the conversion process, 1 g of glass microspheres was placed in 200 ml solution,
and the system was gently stirred continuously. The converted microspheres were washed
three times with distilled water, soaked in anhydrous ethanol to displace residual water
and dried for at least 12 h at room temperature, then for at least 12 h at 90 oC.
Characterization of the converted microspheres was performed using the methods
described in our previous studies [12−15]. Briefly, the microstructure of the surface and
cross-section of the microspheres was examined using scanning electron microscopy
(SEM; S4700; Hitachi, Tokyo, Japan). The phase composition of the converted
microspheres (ground into a powder) was checked using X-ray diffraction XRD; D/mas
2550 v; Rigaku; The Woodlands, TX, USA) and Fourier transform infrared (FTIR)
spectroscopy (NEXUS 670; Thermo Nicolet; Madison, WI, USA). XRD was performed
using Cu Kα radiation (λ = 0.15406 nm) at a scan rate of 1.8o min−1 in the 2θ range
20−70o, while FTIR was performed in the wavenumber range 400−4000 cm −1, (resolution
= 8 cm−1) on pellets pressed from a mixture of 2 mg powder and 198 mg KBr.
The carbon content of the microspheres was measured by a combustion technique
at a commercial laboratory (LECO Corp., St Joseph, MI, USA) and used to determine the
carbonate content of the microspheres.
The specific surface area of the microspheres and the pore size distribution of the
shell wall were measured using nitrogen adsorption (Autosorb-1; Quantachrome,
Boynton Beach, FL, USA). A mass of 300−500 mg of microspheres was weighed and
evacuated for 15 h at 120 oC to remove adsorbed moisture; then the volume of nitrogen
adsorbed and desorbed at different relative gas pressures was measured and used to
construct adsorption-desorption isotherms. The first five points of the adsorption
isotherm, which initially followed a linear trend implying monolayer formation of the
adsorbate, were fitted to the Brunauer-Emmett-Teller (BET) equation to determine the
specific surface area. The pore size distribution was calculated using the Barrett-Joiner-
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Halenda (BJH) method applied to the desorption isotherm [20]. After they were loaded
with BMP2 and after the conclusion of the BMP2 release experiments in vitro (described
later), the dried microspheres were also characterized by SEM and the BET method using
the procedures described above.
2.2. Loading the hollow HA microspheres with BMP2
After sterilization by soaking in anhydrous ethanol and drying in an incubator at
120 oC, some of the hollow HA microspheres were loaded with BMP2 (Shenandoah
Biotechnology Inc., Warwick, PA, USA) and used to study the release profile of the
BMP2 in vitro. A method described previously was used to load the microspheres with
BMP2 [21,22]. Briefly, 10 mg of hollow HA microspheres were placed in a 1 ml
centrifuge tube, and 10 µl of BMP2 solution, formed by dissolving 10 µg BMP2 in 100
µl sterile citric acid (pH = 3.0), was pipetted onto the microspheres. A small vacuum was
applied to the system to replace the air in the hollow HA microspheres with the BMP2
solution. The BMP2-loaded microspheres were dried overnight in a refrigerator at 4 oC
and used immediately without further sterilization.
2.3. Coating the BMP2-loaded microspheres with a biodegradable polymer
The ability to modify the release profile of BMP2 from the hollow HA
microspheres was studied by coating some of the BMP2-loaded microspheres with a
biodegradable polymer, poly(DL-lactic- co-glycolic acid), PLGA (50/50; inherent
viscosity = 0.17 dl g−1; Birmingham Polymers, Inc., Birmingham, AL, USA). In the
coating process, 20 µl of a PLGA solution in chloroform was added to 10 mg hollow HA
microspheres in a centrifuge tube, and the system was dried at 4 oC for 24 h. Two
different concentrations of the PLGA solution (50 mg ml −1 and 200 mg ml−1) were used
to form coatings with different thicknesses.
2.4. Measurement of BMP2 release profile in vitro
In measuring the release of BMP2 from the microspheres, 500 µl of a sterile
solution (pH = 7.4) composed of equal volumes of fetal bovine serum (FBS) and PBS
was added to 10 mg microspheres (coated with PLGA or uncoated) in a micro-centrifuge
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tube, and the samples were incubated at 37 oC. At selected times, the solution was
removed as completely as possible for testing, and replaced with fresh solution. Control
samples containing known amounts of BMP2 in the solution composed of FBS and PBS
were also incubated at 37 oC. The amount of BMP2 present in the control samples was
measured using an enzyme-linked immunosorbent assay (ELISA) kit (PeproTech, Rocky
Hill, NJ, USA). The concentrations of the unknown samples were quantified relative to a
BMP2 standard curve run on the same plate. Three samples of each group were tested at
each time point, and the amount of BMP2 released was expressed as an average ±
standard deviation (SD).
2.5. Animals and surgery
All animal experimental procedures were approved by the Missouri University of
Science and Technology Animal Care and Use Committee, in compliance with the NIH
Guide for Care and Use of Laboratory Animals (1985). 25 Sprague Dawley rats (3
months old; 350 ± 30 g) were housed in the animal care facility and acclimated to diet,
water and housing under a 12 h/12 h light/dark cycle. The rats were anesthetized with an
intramuscularly injected mixture of ketamine and xylazine (0.15 µl per 100 g). The
surgical area was shaved, scrubbed with 70% ethanol, and then draped. With sterile
instruments and an aseptic technique, a cranial skin incision was sharply made in an
anterior-to-posterior direction along the midline. The subcutaneous tissue, musculature
and periosteum were dissected and reflected to expose the calvarium. Bilateral fullthickness defects 4.6 mm in diameter were created in the central area of each parietal
bone using a trephine (4.6 mm outer diameter) attached to an electric drill. The sites were
constantly irrigated with sterile PBS to prevent overheating of the bone margins and to
remove the bone debris.
The calvarial defects were implanted with four groups of implants composed of
hollow HA microspheres:
(1) hollow HA microspheres (positive control);
(2) hollow microspheres loaded with BMP2 (1 µg per defect);
(3) hollow microspheres loaded with BMP2 (1 µg per defect) and coated with
PLGA (50 mg ml−1);
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(4) hollow microspheres loaded with BMP2 (1 lg per defect) and coated with
PLGA (200 mg ml−1).
The defects were randomly implanted with five implants per group, but mixing of
the implants with and without BMP2 was avoided in the same animal. Defects left empty
served as the negative control group. The hollow HA microspheres without BMP2 and
the unfilled defects were randomly assigned to ten animals, while the three groups of
microspheres loaded with BMP2 were randomly assigned to 15 animals. Each animal
received an intramuscular injection of ~200 µl penicillin and ~200 µl buprenorphine
post-surgery. The animals were monitored daily for condition of the surgical wound, food
intake, activity and clinical signs of infection. After 3 or 6 weeks, the animals were
sacrificed by CO2 inhalation, and the calvarial defect sites with surrounding bone and soft
tissue were harvested.
2.6. Histology
The calvarial samples consisting of the defect sites with surrounding bone and
soft tissue were washed with PBS and fixed in 10% formalin solution for 5 days. The
fixed tissue samples were each cut transversely in half; half of each sample was for
paraffin embedding and the other half for methyl methacrylate embedding. The samples
for paraffin sections were decalcified for 4 weeks in EDTA (14 wt.%) under mild
agitation on a rocking plate. After the samples were dehydrated in ethanol and embedded
in paraffin using standard histological techniques, 5 lm thick sections were cut and
stained with hematoxylin and eosin (H&E) [23]. The undecalcified samples were
dehydrated through a graded series of ethanol solutions, and embedded in methyl
methacrylate. Sections were ground to a thickness of 30−40 µm using a micro-grinding
system (EXAKT 400CS, Norderstedt, Germany), and stained using the von Kossa
technique to observe mineralization [24].
2.7. Histomorphometric analysis
Stained sections were examined in a transmitted light microscope (Model BX51;
Olympus America, Center Valley, PA, USA) fitted with a digital color camera (Model
DP71; Olympus). Images were analyzed on a computer using the ImageJ software
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(National Institutes of Health, USA). Sections stained with H&E were used to analyze the
percentage of new bone formed within the defect. The newly formed bone was identified
by outlining the edge of the defect, with the presence of original and new bone being
identified by lamellar and woven bone, respectively. The total defect area was measured
from one edge of the old calvarial bone, including the entire implant and tissue within it,
to the other edge of the old bone. The newly formed bone within this area was then
outlined and measured; the amount of new bone was expressed as a percentage of the
total defect area.
2.8. Statistical analysis
Measurements (n = 5) of the percentage of new bone were expressed as a mean ±
SD. Analysis for differences between groups was performed using one-way analysis of
variance (ANOVA) with Tukey’s post hoc test; differences were considered significant
for P < 0.05.
3. Results
3.1. Characteristics of the as-prepared and PLGA-coated HA microspheres
SEM images of the surface of the as-prepared microspheres are shown in Fig. 1a
and b. Examination of the cross-section of the microspheres in the SEM confirmed that
they were hollow (Fig. 1a, inset). As prepared, the hollow microspheres (external
diameter = 106−150 µm) had a surface area of 102 ± 5 m 2 g−1, a hollow core equal to 0.6
the microsphere diameter and a mesoporous shell wall (pore size = 10−20 nm). SEM
examination and the BET method did not show any measurable differences in the
microstructure and surface area of the microspheres after loading with BMP2 or after the
conclusion of the BMP2 release experiments in vitro at 14 days.
The X-ray and FTIR patterns of the as-prepared microspheres were similar to
those described in our previous work [12], confirming that the microspheres were
composed of HA. The patterns are omitted for the sake of brevity. Briefly, the XRD
patterns showed broad peaks at 2θ values which corresponded to those of a reference HA
(JCPDS 72-1243). The broad peaks indicated that the HA was composed of nanometer-

11
sized crystals, which is consistent with the fine, needle-like particles seen in the SEM
image (Fig. 1b).
The most dominant resonances in the FTIR spectrum were the phosphate ν3
resonance, centered at ~1040 cm−1, and the phosphate ν 4 resonance, with peaks at ~605
and 560 cm−1, which are associated with crystalline HA. The FTIR spectrum also showed
a weak C−O resonance at 1420−1460 cm−1 corresponding to the (CO3)2− group
substituting for (PO4)3− in HA [25], which resulted presumably from CO2 dissolved in the
aqueous medium used in the glass conversion process. The carbonate content of the HA
microspheres determined using a combustion technique described earlier was 2.1 wt.%.
SEM images of the hollow HA microspheres after they were coated with a
solution composed of 50 mg ml−1 or 200 mg ml−1 PLGA are shown in Fig. 1c−f. The
microspheres coated with the 50 mg ml −1 PLGA solution consisted of aggregates bonded
at their contact areas by the PLGA (Fig. 1c). The distribution of the PLGA coating on the
surface of the microspheres was inhomogeneous, with no observable coating on some
parts of the surface (Fig. 1d). When coated with the more concentrated PLGA solution
(200 mg ml−1), a larger amount of PLGA was apparent at the necks between the particles
in the aggregates, and higher-magnification SEM images showed that a larger surface
area of microspheres was coated with a thicker layer (Fig. 1e and f).
3.2. BMP2 release profile in vitro
The amount of BMP2 released at selected time points from the as-prepared and
PLGA-coated HA microspheres into a medium composed of FBS and PBS is shown in
Fig. 2a. As described earlier, at each time point, the medium was removed as completely
as possible and fresh medium was added. The data were used to determine the cumulative
amount of BMP2 released into the medium as a function of time (Fig. 2b). The uncoated
microspheres showed an initial ‘‘burst’’ release at 1 h, followed by a more continuous
release at longer times. In comparison, there appeared to be a delay in the release of
BMP2 from the microspheres coated with the 50 mg ml−1 PLGA solution. The average
amount of BMP released from the coated microspheres at 1 h was significantly smaller
than that for the uncoated microspheres, but it became higher at day 1 and day 3 (Fig. 2a).
Thereafter, the average amount of BMP2 released was lower or comparable to that for the
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uncoated microspheres. The average amount of BMP released from the microspheres
coated with the thicker PLGA solution (200 mg ml −1) at 1 h was significantly lower than
that for the uncoated microspheres, and the amount released into the medium remained
low thereafter.
The average cumulative amount of BMP-2 released into the medium at any time
decreased with increasing concentration of the PLGA coating solution (Fig. 2b). When
the release experiments were terminated after 14 days, the cumulative amount of BMP-2
released from the three groups of microspheres into the medium, determined as a fraction
of the amount initially loaded into the microspheres, was 1.8%, 1.5% and 1.0%,
respectively, for the as-prepared microspheres, the microspheres coated with the 50 mg
ml−1 solution and the microspheres coated with the 200 mg ml −1 solution.
3.3. Bone regeneration in rat calvarial defects implanted with hollow HA microspheres
Fig. 3 shows H&E and von Kossa stained sections of rat calvarial defects
implanted for 6 weeks with the hollow HA microspheres without and with BMP2. New
bone growth in the defects implanted with the microspheres without BMP2 was limited
(17 ± 10%), and occurred mainly at the periphery with the host (old) bone (Fig. 3a and b).
In comparison, new bone formation in the defects implanted with the BMP2-loaded
microspheres was markedly greater (43 ± 6%), and the new bone bridged the defect
within the 6 week implantation period (Fig. 3c and d).
Higher-magnification images of the boxed areas in the H&E stained sections in
Fig. 3 showed limited new bone formation in the pore space between the microspheres
without BMP2 (Fig. 4a). Instead, most of the pore space was filled with fibrous tissue
that contained some blood vessels (red arrow). It appeared that fibrous tissue also
infiltrated the hollow cores of the microspheres.
In comparison, along with the considerable amount of new bone in the pore space
between the BMP2-loaded microspheres (Fig. 4b), blood vessels (red arrow) and bone
marrow-like tissue (yellow arrow) were also present in the new bone.
Von Kossa and H&E stained sections of the defects implanted for 6 weeks with
BMP2-loaded hollow HA microspheres that were coated with PLGA are shown in Fig. 5.
For the microspheres coated with the less concentrated solution (50 mg ml −1 PLGA),
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considerable new bone (46 ± 8%) was formed in the defects, and it almost completely
bridged the defect. In comparison, for the microspheres coated with the more
concentrated solution (200 mg ml−1 PLGA), the amount of new bone formed in the
defects was significantly lower (19 ± 13%). New bone infiltrated the periphery (edge) of
the implants and also formed on the dural (bottom) size.
Since considerable new bone formation was observed at 6 weeks in the defects
implanted with the BMP2-loaded microspheres, uncoated or coated with the 50 mg ml −1
PLGA solution, an implantation time of 3 weeks was also used to examine the timedependence of the new bone formation. The von Kossa and H&E stained sections are
omitted for the sake of brevity. In general, for the same group of implants, the stained
sections at 3 weeks did not show a marked difference from those at 6 weeks.
A box plot of the percent new bone formed in the defects implanted with the four
groups of HA microspheres at 3 and 6 weeks is shown in Fig. 6; the data for the mean ±
SD are summarized in Table I. For each group, the average percent new bone increased
from 3 weeks to 6 weeks, but the difference was not significant. The results also showed
that new bone formation in the defects implanted with the BMP2-loaded implants, either
uncoated or coated with the 50 mg ml −1 PLGA solution, was significantly higher than in
the implants without BMP2 or the BMP2-loaded implants coated with the 200 mg ml −1
PLGA solution. The amount of new bone formed in the BMP2-loaded implants coated
with the 200 mg ml−1 PLGA solution was not significantly different from that for the
implants without BMP2.
4. Discussion
With a hollow core, high surface area and a mesoporous shell wall, the HA
microspheres used in this study could provide a novel growth factor carrier that is
bioactive and osteoconductive. BMP2 is a potent growth factor for stimulating bone
formation, but it is limited by high cost and increasing concerns about adverse biological
effects associated with the use high doses [26,27]. Consequently, the ability to control the
sustained release of BMP-2 at clinically desirable rates is relevant in bone regeneration.
The feasibility of combining the hollow HA microspheres with a biodegradable polymer
coating to control the release profile of BMP2 was shown. This study also showed that
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when loaded with BMP2, the hollow HA microspheres had a considerable capacity to
regenerate bone in vivo, despite a slow and limited capacity to release BMP2 in vitro.
4.1. Hollow HA microspheres as a carrier for BMP2
The results showed that BMP2 was released continuously but slowly from the
hollow HA microspheres into the medium in vitro (Fig. 2b). BMP2 has a high affinity for
HA and, consequently, its release rate from HA in vitro is often low. The adsorbed BMP2
is reported to be strongly immobilized on the surface of the HA by electrostatic and other
interactions, such as hydrogen bonding [28]. This strong interaction makes it difficult for
the BMP2 to be displaced from the HA surface by competitive adsorption from other
proteins [29]. In one study, 23% of the BMP2 initially adsorbed on a nanostructured HA
coating was released at 21 days, but the release rate was almost doubled from a coarsegrained HA coating [30]. In another study, after an initial release of 22% within the first
24 h, subsequent release of BMP2 from a porous calcium phosphate cement was limited
[29]; the addition of a carrier protein, BSA, had little effect on the BMP2 release profile.
While there is a tendency for low release of BMP2 from calcium phosphate
bioceramics in vitro, the amount released from the hollow HA microspheres used in this
study was still lower than those observed from more conventional HA materials [29,30].
A few factors might have contributed to the much lower release rate, but the unique
structural features of the hollow HA microspheres, such as the high-surface-area
mesoporous shell, might be the most important. The theoretical amount of BMP2 that can
be adsorbed onto the surface of HA has been estimated to be ~800 µg m −2 [30]. The
specific surface area of the hollow HA microspheres used in this study was ~100 m 2 g−1.
Consequently, ~800 µg of BMP-2 could theoretically be adsorbed on the surface of the
10 mg of HA microspheres used in these experiments. Since the total amount of BMP2
initially loaded into the hollow HA microspheres was 1 µg, therefore a large amount of
the HA surface area would remain available for adsorption. Presumably the desorbed
BMP2 could be readily re-adsorbed on the largely free HA surface, which would
markedly reduce the amount of BMP2 released into the medium. Furthermore, the
tortuous mesopores of the shell wall could make migration of BMP2 from the hollow
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core or from the pores to the external surface of the microspheres difficult because of the
large surface area available for adsorption.
Other factors that could also contribute to the limited amount BMP2 released in
vitro are the limited flow of the liquid media used in the release experiments, and the
tendency of the microspheres to aggregate. However, a higher release rate of BMP2 from
the microspheres can be expected in vivo because of a higher degradation rate of the HA
due to cell-mediated degradation in addition to dissolution-mediated degradation [31,32]
and the higher solubility of proteins in vivo. If required, the release of BMP2 from the asprepared microspheres can be improved by increasing the dissolution or degradation rate
of the HA [28−30], which is dependent on the composition and structure of the HA
[33,34]. The HA microspheres used in the present study had a nearly stoichiometric
composition and, consequently, a low degradation rate. As described earlier, no
measurable degradation of the microspheres was observed after the two-week BMP2
release experiments in vitro. Our previous experiments showed no measurable
degradation of the microspheres at 12 weeks in rat calvarial defects [15]. In our ongoing
experiments, hollow HA microspheres with varying amounts of carbonate substitution
are being prepared by a similar glass conversion process and they are being evaluated in
vitro and in vivo.
The rate at which the BMP2 is released with time is also relevant in the use of
these hollow HA microspheres as a carrier in bone regeneration. In particular, a high
initial burst release of BMP2 has often been observed from HA carrier materials [35]. A
burst release of BMP2 can induce inflammatory reactions which are believed to be
beneficial for promoting bone formation, but it can also cause significant adverse
biological effects. While a reduction in the BMP2 dose delivered in vivo could reduce
those side effects, a high dose is often required to induce significant bone formation
[26,36].
In order to test the ability to modify the BMP2 release rate, the hollow HA
microspheres were coated with PLGA after they were loaded with BMP2. PLGA
solutions with two different concentrations (50 mg ml −1 and 200 mg ml−1) were used to
control the thickness or the amount of the PLGA deposited on the microspheres. It is
expected that the PLGA could reduce the size of the mesopores in the shell wall of the
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microspheres or completely block the pores, depending on the concentration of the
coating solution. Consequently, the initial release of any unadsorbed BMP-2 from the
microspheres would be impeded.
The results showed that both coatings were effective in reducing the amount of
BMP2 released during the first hour when compared to the uncoated microspheres (Fig.
2a); the amount of BMP2 released from the coated microspheres was 4−5 times lower
than that for the uncoated microspheres. Subsequently, the amount of BMP2 released
from the microspheres coated with the 50 mg ml −1 PLGA solution increased, and the
cumulative amount of BMP2 released was not significantly different from that of the
uncoated microspheres (Fig. 2b). In comparison, the amount of BMP2 released from the
microspheres coated with the 200 mg ml −1 solution remained at a much lower value,
presumably because the larger PLGA coverage provided a greater barrier to the release of
BMP2.
The results showed the feasibility of combining the hollow HA microspheres with
a biodegradable polymer coating to control the release profile of BMP2. However, it is
expected that optimization of the coating will depend on the clinical application. For
example, the use of a much higher BMP2 dose (1500 µg ml −1), as in some clinical
applications [37], will require the coating thickness to be adjusted accordingly in order to
achieve optimum control on the release profile.
4.2. BMP2-loaded hollow HA microspheres as implants in bone regeneration
The in vivo experiments showed the effectiveness of using the hollow HA
microspheres as a carrier to deliver BMP2 in the stimulation of bone regeneration.
Loading the microspheres with BMP2 significantly enhanced new bone formation in the
rat calvarial defects at 3 weeks and the amount of new bone did not change significantly
at 6 weeks (Fig. 6). This indicates that the BMP2-induced new bone formation was
almost completed as early as 3 weeks, although bone remodeling could continue
thereafter. As the pore space between the microspheres was almost completely infiltrated
with new bone at 3 weeks, there was little opportunity for a significant further increase at
6 weeks.
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An interesting observation was the effect of the PLGA coating on the capacity of
the BMP2-loaded microspheres to regenerate bone. New bone formation in the implants
coated with the PLGA solution of lower concentration (50 mg ml −1) was not significantly
different from that in the uncoated implants whereas new bone formation in the implants
coated with the PLGA solution of higher concentration (200 mg ml −1) was significantly
lower (Fig. 6). In fact, the percent new bone formed in the BMP2-loaded implants coated
with the 200 mg ml−1 PLGA solution was comparable to that for the microspheres
without BMP2. The reason for the difference in bone generation among the uncoated and
coated implants loaded with BMP is not clear at present and it is the subject of ongoing
studies. However, a few factors that could contribute to the difference are briefly
discussed at this stage.
The BMP2 release profiles in vitro showed that while the average BMP2 release
rate (amount per period) was fairly similar among the three groups of microspheres after
3 days, there appeared to be more pronounced differences at earlier times (Fig. 2a). A
possible explanation therefore is that differences in the initial release within the first 3
days could be responsible for the differences in new bone formation in the three implant
groups loaded with BMP2. The cumulative amount of BMP2 released from the uncoated
microspheres and the microspheres coated with the 50 mg ml −1 solution (8−10 µg) was
more than twice the value (~4 µg) for microspheres coated with the 200 mg ml −1 solution.
The higher dose of BMP2 in the defect site released in the initial time period from the
uncoated microspheres and the microspheres coated with the 50 mg ml −1 PLGA solution
might have reached the threshold value to trigger the repairing cascades. In comparison,
the lower BMP2 dose released from the microspheres coated with the 200 mg ml −1 PLGA
solution might have been below the threshold value. The time at which exogenous BMP2
is administered can be critical. In a previous study [38], the administration of BMP2 at
day 0 or day 4 post-fracture was found to enhance periosteal callus formation, bone
mineral content, and biomechanical properties when compared to later administration of
BMP2 (day 8).
Another factor that could contribute to the difference in bone regeneration among
the BMP2-loaded implants is the modification of the surface properties of the HA by the
PLGA coating. As described earlier, the coating produced by the 50 mg ml −1 PLGA
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solution was inhomogeneous and mainly concentrated at the necks between the
microspheres, leaving a large area of the microsphere surface uncoated (Fig. 2c and d).
The microspheres could still provide a large area of osteoconductive surface for bone
regeneration. This, combined with the release of BMP2, apparently did not reduce the
capacity of the coated microspheres to regenerate bone. In comparison, a larger fraction
of the microsphere surface was coated with the 200 mg ml −1 PLGA solution (Fig. 2e and
f), which markedly reduced the osteoconductive surface area. The slow release of BMP2
from the microspheres presumably compensated for the reduction in osteoconductive
surface area, resulting a similar capacity to regenerate bone as the uncoated microspheres
without BMP2 (Fig. 6).
It is also possible that the coating process could reduce the bioactivity of the
BMP2 in the microspheres. At 14 days when the in vitro release experiments were
concluded, the difference in the cumulative amount of BMP2 released from the
microspheres coated with the 50 mg ml −1 and the 200 mg ml−1 solution was small (1.5%
vs. 1.0%). A greater reduction in the bioactivity of the BMP2 released from the
microspheres coated with the more concentrated solution could contribute to the
significantly lower bone regeneration in those implants.
Another possible explanation for the difference in bone regeneration among the
BMP2-loaded implants might be the critical role played by the immobilized BMP2 in
bone repair (when compared to the released BMP2). It has been suggested that BMPs
immobilized in extracellular matrices are essential for the osteoblastic differentiation of
cells [39]. The BMP2 in the uncoated microspheres or the microspheres coated with 50
mg ml−1 PLGA solution was presumably able to interact with cells. In comparison, the
thicker coating on the microspheres coated with the 200 mg ml −1 PLGA solution
presumably made the BMP2 in those microspheres inaccessible to the cells. Further
studies are required to elucidate the mechanism.
Table II gives a comparison of the amount of new bone formed in rat calvarial
defects implanted with the hollow HA microspheres (with or without BMP2) used in this
study and with a variety of biomaterials implanted in the same animal model. This list is
not meant to be exhaustive; instead it provides data for a few selected bioactive materials:
hollow HA microspheres, similar to those used in this study, loaded with TGFb1 (5 µg
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per defect) [15]; particles (150−250 µm) of silicate 45S5 bioactive glass [40]; 3-D
scaffolds of a borate bioactive glass (designated 13-93B3) with a microstructure similar
to dry human trabecular bone [41]; 3-D scaffolds of a calcium-deficient HA (CDHA)
without or with BMP2 (2 µg per defect) [42]; and 3-D scaffolds of a commercial biphasic
calcium phosphate (BCP) without or with BMP2 (2.5 µg per defect) [43]. Silicate 45S5
glass is included in this comparison because it is considered to be the gold standard for
bioactive glasses, whereas the 13-93B3 bioactive glass scaffolds are receiving interest for
bone repair applications. In common with the HA used in the present study, the CDHA
and BCP are calcium phosphate biomaterials.
For implants composed of the hollow HA microspheres used in this study, the
data show that BMP2 is considerably more effective in stimulating new bone formation
than TGFβ1. The data also indicate that the hollow HA microspheres loaded with BMP2
have a greater capacity to regenerate bone when compared to silicate 45S5 bioactive
glass particles and porous scaffolds of borate 13-93B3 bioactive glass. The hollow HA
microspheres also showed a better capacity to regenerate bone at 6 weeks when
compared to highly porous scaffolds of the CDHA implanted for 8 weeks; when loaded
with BMP2, the microspheres also showed a better capacity to regenerate bone than the
CDHA scaffolds loaded with twice the amount of BMP2. New bone formation in the
defects implanted with the hollow HA microspheres (without BMP2) for 6 weeks was
comparable to that in highly porous commercial BCP scaffolds at 8 weeks. When loaded
with BMP2, new bone formation in the BCP scaffolds was higher than that in the BMP2loaded hollow HA microspheres. However, the implantation time was longer and the
BMP2 loading was 2.5 times the amount used in the present work.
5. Conclusions
Hollow HA microspheres with a high-surface-area mesoporous shell wall can
provide a potential novel carrier for BMP2 in bone regeneration. The capacity of the
microspheres to deliver BMP2 in vitro was shown, although the amount of BMP2
released into the medium was small (1.8% after 2 weeks). The release of BMP2 from the
hollow HA microspheres, particularly at early times, can be reduced and controlled by
coating the microspheres with different amounts of a biodegradable polymer, PLGA,
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indicating the feasibility of controlling the initial burst release of BMP2 typically
observed from HA implants. When loaded with BMP2 (1 µg per defect), the hollow HA
microspheres, uncoated or coated with a 50 mg ml −1 PLGA solution, significantly
enhanced bone regeneration in rat calvarial defects within 3−6 weeks. Bone regeneration
in those two groups of BMP2-loaded HA microspheres was considerably higher than in
45S5 glass particles (150−250 µm), the gold standard of bioactive glasses.
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Fig. 1. Low- and high-magnification SEM images of the surface of hollow HA
microspheres as prepared (a, b), and after coating with solutions containing 50 mg ml -1
PLGA (c, d), and 200 mg ml-1 PLGA (e, f), followed by drying. The inset in (a) shows a
cross-section of a hollow HA microsphere.
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Fig. 2. (a) Amount of BMP2 released from hollow HA microspheres into a medium
composed of equal volumes of FBS and PBS at selected time periods; (b) average
cumulative amount of BMP2 released from the microspheres into the medium as a
function of time. Data for the as-prepared microspheres (uncoated), and microspheres
coated with 50 mg ml-1 PLGA solution (50 mg ml-1), and with 200 mg ml-1 PLGA
solution (200 mg ml-1).
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Fig. 3. (a, c) H&E and (b, d) von Kossa stained sections of rat calvarial defects implanted
for 6 weeks with (a, b) as-prepared hollow HA microspheres (without BMP2) and (c, d)
hollow HA microspheres loaded with BMP2 (1 µg per defect). HB = host (old) bone; NB
= new bone.
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Fig. 4. High-magnification images of H&E stained sections of rat calvarial defects
implanted for 6 weeks with (a) as-prepared hollow HA microspheres (without BMP2)
and (b) hollow HA microspheres loaded with BMP2 (1 µg per defect). The images shown
in (a) and (b) correspond to the boxed area outlined in Fig. 3a and b, respectively. HB =
host (old) bone; NB = new bone; red arrows indicate blood vessels; yellow arrows
indicate bone marrow-like tissue.
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Fig. 5. (a, c) H&E and (b, d) von Kossa stained sections of rat calvarial defects
implanted for 6 weeks with hollow HA microspheres loaded with BMP2 and coated with
different amounts of PLGA formed from solutions containing 50 mg ml -1 PLGA (a, b)
and 200 mg ml-1 PLGA (c, d). HB = host (old) bone; NB = new bone.
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Fig. 6. Box plot comparing the percent new bone formed in rat calvarial defects
implanted for 3 weeks (3 W) and 6 weeks (6 W) with four groups of implants composed
of hollow HA microspheres: (a) as prepared; (b) loaded with BMP2 (denoted
BMP2/Uncoated); (c) loaded with BMP2 and coated using a 50 mg ml -1 PLGA solution
(denoted BMP2/Coated(50)); (d) loaded with BMP2 and coated using a 200 mg ml -1
PLGA solution (denoted BMP2/Coated(200)). The median and mean values, interquartile
range, and the high and low values for each group are shown. (n = 5; P < 0.05).
Table I. Percentage of new bone (mean ± SD) formed in rat calvarial defects implanted
for 3 weeks and 6 weeks with four groups of hollow HA microspheres used in this study:
microspheres without BMP2; microspheres with BMP2; BMP2-loaded microspheres
coated with 50 mg ml-1 PLGA solution; BMP2-loaded microspheres coated with 200 mg
ml-1 PLGA solution.
HA microspheres

Implantation time
3 weeks

6 weeks

Without BMP2

13  5

17  10

With BMP2

39  10

43  6

With BMP2; PLGA coating (50 mg ml-1)

38  11

46  8

With BMP2; PLGA coating (200 mg ml-1)

15  8

19  13
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Table II. Comparison of percent new bone (mean ± SD) formed in rat calvarial defects
implanted with the hollow HA microspheres (106−150 μm) used in this study, and with
selected bioactive ceramic and glass implants.
Implant

Growth factor

Implantation

% new

time (weeks)

bone

Reference

Hollow HA microspheres

−

6

17  10

This study

Hollow HA microspheres

BMP2

6

43  6

This study

12

19  4

[15]

−

12

19  3

[40]

−

12

15  3

[41]

−

8

10  3

[42]

Calcium-deficient HA (porosity

BMP2

8

27  4

[42]

= 75%; pore size = 400-500 µm)

(2 µg/defect)

BCP (porosity = 70%; pore size

−

8

23  5

[43]

BMP2

8

55  8

[43]

(1 µg/defect)
Hollow HA microspheres

TGF1
(5 µg/defect)

45S5 silicate glass particles
(150-250 µm)
13-93B3 borate glass scaffold
(porosity = 77%; pore size =
200-400 µm)
Calcium-deficient HA (porosity
= 75%; pore size = 400-500 µm)

= 300-600 µm and <10 µm)a
BCP (porosity = 70%; pore size
= 300-600 µm and <10 µm)a
a

(2.5 µg/defect)

BCP: biphasic calcium phosphate (HA:βTCP = 20:80); two-thirds of the porosity in the range 300-600
µm; one-third of the porosity <10 µm.
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ABSTRACT
Hollow hydroxyapatite (HA) microspheres, with a high-surface-area mesoporous
shell, can provide a unique bioactive and osteoconductive carrier for proteins to stimulate
bone regeneration. However, synthetic HA has a slow resorption rate and a limited ability
to remodel into bone. In the present study, hollow HA microspheres with controllable
amounts of carbonate substitution (0−12 wt.%) were created using a novel glass
conversion route and evaluated in vitro and in vivo. Hollow HA microspheres with ~12
wt.% of carbonate (designated CHA12) showed a higher surface area (236 m 2 g−1) than
conventional hollow HA microspheres (179 m2 g−1) and a faster degradation rate in a
potassium acetate buffer solution. When implanted for 12 weeks in rat calvarial defects,
the CHA12 and HA microspheres showed a limited capacity to regenerate bone but the
CHA12 microspheres resorbed faster than the HA microspheres. Loading the
microspheres with bone morphogenetic protein-2 (BMP2) (1 µg per defect) stimulated
bone regeneration and accelerated resorption of the CHA12 microspheres. At 12 weeks,
the amount of new bone in the defects implanted with the CHA12 microspheres (73 ± 8%)
was significantly higher than the HA microspheres (59 ± 2%) while the amount of
residual CHA12 microspheres (7 ± 2% of the total defect area) was significantly lower
than the HA microspheres (21 ± 3%). The combination of these carbonate-substituted HA
microspheres with clinically safe doses of BMP2 could provide promising implants for
healing non-loaded bone defects.
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1. Introduction
The healing of large bone defects resulting from trauma, resection of tumors or
congenital diseases represents a common and significant problem in craniofacial and
orthopedic surgery. Clinically those defects are reconstructed using autologous bone
grafts, allografts and biocompatible synthetic materials [1−3]. Autologous bone grafts are
the gold standard for treatment while bone allografts are the most commonly used bone
grafts. However, they suffer from limitations such as limited supply, donor site morbidity
(autografts), high cost, uncertain healing and risk of infection (allografts) [4]. Because of
these limitations, the need for synthetic biomaterials continues to grow.
A variety of synthetic bone graft substitutes have been developed over the last
several decades [1,2]. They include calcium phosphate bioceramics such as
hydroxyapatite (HA), beta-tricalcium phosphate (β-TCP), biphasic calcium phosphate
(BCP), calcium phosphate cements, bioactive glass and biodegradable polymers.
However, synthetic bone graft materials generally lack the osteoinductivity and
osteogenicity of autogenous bone grafts, functioning mainly as osteoconductive implants
[1,5−7]. The use of synthetic biomaterials by themselves commonly fails to produce
clinically significant bone formation in a clinically relevant time [7,8]. In practice,
synthetic biomaterials are often combined with autologous bone, osteogenic growth
factors or cells in order to achieve reliable reconstruction of bone [7,9−11].
Calcium phosphate bioceramics such as HA, β-TCP and BCP have been used in
dentistry and medicine for bone repair and augmentation for over 30 years [12,13]. They
have a high affinity for binding and concentrating proteins which make them ideal
carriers for growth factors such as bone morphogenetic protein-2 (BMP2) and bioactive
peptides [14,15]. Several studies have shown that when combined with BMP2, calcium
phosphate bioceramics in the form of porous particles, granules or three-dimensional
scaffolds enhanced osteogenesis in animal models when compared to the calcium
phosphate bioceramics without BMP2 [16−21].
HA is often considered to be a prototype biomaterial for bone repair and
augmentation because of its similarity to the mineral constituent of living bone [22].
However, synthetic HAs with a nearly stoichiometric composition often have a low
resorption rate, resulting in the material remaining nearly bioinert in vivo over a long
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period [23,24]. In comparison, biological HAs contain minor and trace elements and are
therefore not pure HA. The most important minor substituents are CO 3, Mg and Sr. The
ability of the implant to remodel into bone within a clinically relevant time is desirable
for bone repair. The degradation of HA and other calcium phosphate bioceramics can
occur by two processes: solution-mediated dissolution [14,23], and cell-mediated
degradation resulting from the activities of osteoclastic cells [25−27]. Ionic substitution
by (CO3)2−, Mg2+ and Sr2+, fine particle size, high surface area and high porosity have
been shown to improve the solution-mediated degradation rate of HA [14,27−30]
whereas (CO3)2− substitution and fine grain size have been found to be desirable for
osteoclastic resorption [25,26].
In the last few years, we have been developing a hollow HA microsphere
technology to address the need for bone graft substitutes that could approach the
combined osteoconductive, osteoinductive and osteointegrative properties of autologous
bone grafts. The hollow HA microspheres, prepared by a novel glass conversion route
near room temperature, have a high surface area (>100m 2 g−1) and a mesoporous shell
wall (pore size=10−20nm) composed of nanocrystalline HA particles[31]. Our previous
studies showed that hollow HA microspheres can function as a carrier for the controlled
delivery of proteins and growth factors [32,33]. When loaded with BMP2 (1 µg per
defect), the hollow HA microspheres (106−150 μm) enhanced bone regeneration in rat
calvarial defects (4.6mmin diameter) when compared to similar microspheres without
BMP2, resulting in bridging of the defects by new bone within 6 weeks [33]. However,
little resorption of the HA microspheres was observed in the defects within the six-week
implantation period.
The objective of this study was to create hollow HA microspheres with a faster
degradation rate and test their performance in vitro and in vivo. The glass conversion
process used in our previous studies was modified to create hollow HA microspheres
with controllable amounts of (CO3)2− substitution. Carbonate-substituted HA
compositions were used because they have been shown to result in enhanced degradation
or resorption rates. The dissolution of the microspheres in a potassium acetate buffer
solution and their degradation by osteoclastic cells was studied in vitro. Microspheres
with or without BMP2 were implanted in rat calvarial defects in vivo and their ability to
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resorb and to regenerate bone was evaluated at 12 weeks postimplantation using
histomorphometric methods.
2. Materials and methods
2.1. Preparation and characterization of hollow HA microspheres
Hollow HA microspheres with a nearly stoichiometric composition were prepared
by reacting solid glass microspheres in an aqueous phosphate solution, as described in
detail in our previous study [31]. Briefly, borate glass microspheres (150−250 μm) with
the composition 15CaO, 11Li2O, 74B2O3 (wt.%) were reacted for 7 days in 0.02 M
K2HPO4 solution at 37 °C and starting pH = 9.0. A mass of 4 g glass microspheres was
reacted in 800 ml of the phosphate solution in all of the conversion experiments. The
converted microspheres were washed 3 times with deionized water, soaked in anhydrous
ethanol to displace residual water, and dried for at least 12 h at room temperature then for
at least 12 h at 90 °C. Carbonate-substituted HA (CHA) microspheres with varying
carbonate content were prepared using the same method but the phosphate solution used
in the conversion process contained different concentrations of carbonate ions by adding
KHCO3 to the solution (Table I).
Characterization of the converted microspheres (HA and CHA) was performed
using the methods described previously [31]. Briefly, the microstructure of the surface
and cross section of the microspheres was examined using scanning electron microscopy
(SEM) (S4700; Hitachi, Tokyo, Japan). X-ray diffraction (XRD) (D/mas 2550 v; Rigaku;
The Woodlands, TX, USA) was used to check for the presence of crystalline phases in
the converted microspheres while Fourier transform infrared (FTIR) spectroscopy
(NEXUS 670; Thermo Nicolet; Madison, WI, USA) was used to determine the chemical
groups in the composition. The specific surface area, average pore size and pore size
distribution of the shell of the converted microspheres were measured using nitrogen
adsorption (Autosorb-1; Quantachrome, Boynton Beach, FL, USA). In addition, the
carbon content of the converted microspheres was determined at a commercial laboratory
using a Carbon/Sulfur Analyzer (CS844; LECO Corp.; St. Joseph, MI, USA) designed to
measure the carbon and sulfur content in metals and ceramics using a combustion method.
Three samples from each group of microspheres were analyzed and the carbonate content
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was determined by assuming that all the measured carbon in the microspheres was
present as carbonate (CO3).
2.2. Degradation of hollow HA and CHA microspheres in vitro
The solubility of the converted microspheres was determined by measuring the
concentration of Ca2+ ions released from the microspheres as a function of immersion
time in an acidic buffer (0.1 M potassium acetate; pH = 5.0) at 37 °C [23,34], using
inductively coupled plasma optical emission spectrometry (ICP-OES) (Optima 2000DV;
Perkin Elmer, Waltham, MA). A fixed surface area to volume ratio (50 m 2 l−1) of HA
microspheres to potassium acetate solution was used. Three samples from each group
were analyzed at each time point. The solubility of granules composed of medical grade
beta-tricalcium phosphate (β-TCP) (Himed; Old Bethage, NY) was used as a reference
for comparison.
2.3. Osteoclastic resorption of hollow HA and CHA microspheres in vitro
Cell-mediated degradation of the converted microspheres was studied using
induced osteoclast cultures [26,35]. The human monocyte-like cell line TIB-71 (ATCC,
USA)was cultured in Dulbecco's modified Eagle's medium(DMEM) supplemented with
10 vol.% fetal bovine serum (FBS) (Sigma-Aldrich, St. Louis, MO) and 1 vol.%
penicillin/streptomycin (Invitrogen) at 37 °C in a humidified atmosphere of 5% CO 2. The
microspheres were sterilized by soaking in anhydrous ethanol and exposure to ultraviolet
light. Then TIB-71 cells were seeded at a concentration of 10 5 cells/ml and incubated at
37 °C in a humidified CO2 atmosphere. At day 1, 50 ng/ml RANKL (Biolegend, San
Diego, CA) was added to the culture media to induce the differentiation of the TIB-71
cells to osteoclasts. The media was replaced with fresh media containing 50 ng/ml
RANKL every 2 days for the remainder of the experiment.
The microspheres were removed from the culture media at day 7 and rinsed with
0.1 M phosphate-buffered saline (PBS). Then the cells were fixed with 2%
paraformaldehyde plus 2% glutaraldehyde in 0.1 M cacodylate buffer overnight at 4 °C.
Each sample was rinsed with 0.1 M cacodylate buffer and fixed in 2% osmium tetroxide
for 2 h at room temperature. The fixed samples were dehydrated in a graded ethanol
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series, soaked in hexamethyldisilazane (HMDS) and dried in air to allow the liquid to
fully evaporate. The dried samples were sputter-coated with gold and observed in a
scanning electron microscope (S-4700; Hitachi) at an accelerating voltage of 15 kV and a
working distance of 13 mm.
2.4. Animals and surgery
Hollow HA and CHA microspheres, as-prepared or loaded with BMP2, were
implanted in rat calvarial defects to evaluate their response in osseous defects. After
being sterilized by soaking in anhydrous ethanol and exposure to ultraviolet light, the
microspheres were loaded with BMP2 using a procedure described in detail in our
previous study [33]. Briefly, 10 mg of hollow microspheres were placed in a 1ml
centrifuge tube, and 10 μl of BMP2 solution, formed by dissolving 10 µg BMP2
(Shenandoah Biotechnology Inc., Warwick, PA) in 100 μl sterile citric acid (pH = 3.0),
was pipetted onto the microspheres. A small vacuum was applied to the system to replace
the air in the hollow microspheres with theBMP2 solution. The BMP2 solution was
completely absorbed in the microspheres. The BMP2-loaded microspheres were dried
overnight in a refrigerator at 4 °C until used in the animal experiments the following day.
All animal experimental procedures were approved by the Missouri University of
Science and Technology Animal Care and Use Committee, in compliance with the NIH
Guide for Care and Use of Laboratory Animals (1985). Sprague Dawley rats (3 months
old; 350 ± 30 g) were housed in the animal care facility and acclimated to diet, water and
housing under a 12 h/12 h light/dark cycle. The rats were anesthetized with an
intramuscularly injected mixture of ketamine and xylazine (1.5 μl/kg). The surgical area
was shaved, scrubbed with 70% ethanol and iodine, and then draped. With sterile
instruments and an aseptic technique, a cranial skin incision was sharply made in an
anterior to posterior direction along the midline. The subcutaneous tissue, musculature
and periosteum were dissected and reflected to expose the calvarium. Bilateral fullthickness defects 4.6 mm in diameter were created in the central area of each parietal
bone using a PBS-cooled trephine drill without disturbing the dura mater. The sites were
constantly irrigated with sterile PBS to prevent overheating of the bone margins and to
remove the bone debris. The bilateral defects were randomly implanted with 7 replicates
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per group but microspheres with and without BMP2 were not mixed in the same animal.
Each defect was implanted with the same mass of microspheres (10 mg). The number of
replicates per group (n = 7) was based on our previous studies [33]. The periosteum and
skin were repositioned and closed using wound clips. The animals were given a dose of
ketoprofen (3 mg/kg mass of the animal) intramuscularly and 0.2 ml penicillin
subcutaneously post-surgery, and they were monitored daily for the condition of the
surgical wound, food intake, activity and clinical signs of infection. After 12 weeks, the
animals were sacrificed by CO2 inhalation and the calvarial defects with surrounding
bone and soft tissue were harvested for subsequent evaluation. This implantation time
was used because our previous study showed that for the same animal model, the amount
of new bone in the defects implanted with the HA microspheres without BMP2 was
limited at 6 weeks [33].
2.5. Histologic processing
The harvested calvarial samples were fixed in 10% formaldehyde for 5 days,
washed with deionized water and then cut in half. Half of each sample was for paraffin
embedding while the other half was for poly(methyl methacrylate) (PMMA) embedding.
The samples for paraffin embedding were decalcified in 14% ethylenediaminetetraacetic
acid (EDTA) for 2 weeks, dehydrated in a graded series of ethanol and embedded in
paraffin using routine histological techniques [36]. Then the samples were sectioned to 5
μm using a microtome and stained with hematoxylin and eosin (H&E). The undecalcified samples were dehydrated in a graded series of ethanol and embedded in
PMMA. Sections were affixed to acrylic slides, ground down to 40 μm using a surface
grinder (EXAKT 400CS, Norderstedt, Germany) and stained using the von Kossa method.
Transmitted light images of the stained sections were taken with an Olympus BX 50
microscope connected to a CCD camera (DP70, Olympus, Japan).
2.6. Histomorphometric analysis
Histomorphometric analysis was carried out using optical images of the stained
sections and the ImageJ software (National Institutes of Health, USA). One section across
the diameter of each defect was analyzed. The amount of new bone and residual HA (or
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CHA) microspheres in the defects was evaluated from the H&E stained sections. The
entire defect area was determined as the area between the two defect margins, including
the HA microspheres and the tissues. The newly formed bone and residual microspheres
within the defect area were then outlined and measured. The area of new bone and
residual HA microspheres was expressed as a percentage of the total defect area. The von
Kossa positive area in the defects implanted with microspheres was determined from the
von Kossa stained sections, which yielded the combined amount of mineralized bone and
hydroxyapatite as both bound the silver nitrate.
2.7. Statistical analysis
The data are presented as a mean ± standard deviation (SD). Analysis for
differences between groups was performed using one-way analysis of variance (ANOVA)
with Tukey's post hoc test. Differences were considered significant for p < 0.05.
3. Results
3.1. Characteristics of converted microspheres
The BET surface area, average pore size (diameter or width) and carbonate
content of the three groups of converted microspheres used in the present study (external
diameter = 150−250 μm) are summarized in Table I. The microspheres designated HA,
corresponded to the microspheres used in our previous studies [31−33]. The carbonate
content of those HA microspheres was not determined previously but the results of the
present study showed that they contained 2.1 wt.% carbonate. The carbonate substitution
presumably resulted from dissolved CO2 in the aqueous phosphate solution used in
converting the glass microspheres to hydroxyapatite microspheres. However, for
consistency with our previous studies, we will continue to refer to those microspheres as
HA microspheres. The microspheres formed by conversion in the aqueous phosphate
solutions that contained 0.135 and 0.27 M KHCO 3, with a carbonate content of 8.6 and
12.4 wt.%, respectively, will be referred to as CHA9 and CHA12. The surface area of the
CHA9 and CHA12 microspheres was higher than the HA microspheres, presumably
because of a finer particle (or pore) size. The average pore size of the shell was 11, 8 and
7 nm, respectively, for the HA, CHA9 and CHA12 microspheres.
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SEM images of the cross section of the microspheres confirmed that they were
hollow (Fig. 1). The surface of the HA microspheres showed needle-like particles, similar
to those for the HA microspheres prepared previously [31−33]. In comparison, the
surface of the CHA9 and CHA12 microspheres was composed of nearly spherical
particles. The peaks in the XRD patterns of the HA, CHA9 and CHA12 microspheres
corresponded to a reference hydroxyapatite (JCPDS 72-1243) (Fig. 2a). However, the
height of the major peak for the CHA9 and CHA12 groups decreased by 30% and 40%,
respectively, and the half-width increased by 10% and 15%, respectively, relative to the
major peak for the HA group.
The most dominant resonances in the FTIR spectra (Fig. 2b) of the three groups
of microspheres were the phosphate ν3 resonance, centered at ~1040 cm −1, and the
phosphate ν4 resonance with peaks at ~605 and 560 cm −1 that are associated with
crystalline HA [37,38]. The peaks at ~1450−1490 cm −1 are associated with the C−O ν3
resonance while the peak at 875 cm−1 is associated with the CO3 2− ν2 resonance [39].
The increase in peak area from HA to CHA12 indicated an increase in carbonate content,
in accordance with the results of Table I. These resonances also indicated that a B-type
substitution in which carbonate ions substitute for the phosphate ions in the
hydroxyapatite lattice [40].
3.2. Solution mediated degradation in vitro
The solution-mediated degradation of hydroxyapatite is generally considered to
be a congruent process, so the dissolution rate can be described by the rate of Ca 2+ ion
release. The cumulative amount of Ca2+ ions released from the HA, CHA9 and CHA12
microspheres into the potassium acetate buffer solution (at a constant surface area to
volume ratio) is shown as a function of immersion time in Fig. 3a. The release profiles of
the three groups of microspheres showed the same trend. The release was more rapid
initially (up to ~10 h), slowed considerably thereafter and almost ceased after ~24 h. At
any immersion time, the amount of Ca2+ ions released into the medium increased with the
carbonate content of the microspheres. However, the amount of Ca 2+ ions released from
the CHA12 microspheres was still considerably lower than the β-TCP reference material.
The amount of Ca2+ ions released into the medium at an immersion time of 1 h (Fig. 3b)
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showed a significant increase with increasing carbonate substitution but the amount of
Ca2+ ions released from the CHA12 microspheres was significantly smaller than the βTCP reference material.
3.3. Cell mediated degradation in vitro
After 7 days of incubation, giant cells with multiple nuclei were found on the
surface of the microspheres (Fig. 4a1−3). These osteoclast-like cells had an average size
of ~50 μm. After the cells were rinsed off, pits became visible on the surface of the
microspheres (Fig. 4b1−3), showing degradation of the microspheres by the osteoclastic
cells. The surface of the CHA12 microspheres appeared to have deeper pits than the HA
and CHA9 microspheres. However, because of curved surface of the microspheres and
the size of the cells relative to the microsphere diameter, the amount of the pitted area, as
a fraction of the surface area of the microspheres could not be readily quantitated.
3.4. Bone regeneration in rat calvarial defects in vivo
Optical images of the H&E stained sections of the rat calvarial defects implanted
with the HA and CHA12 microspheres without BMP2 are shown in Fig. 5. For both
implant groups, new bone formation was limited and it was confined mainly to the edge
(periphery) of the defect. Although the same mass of HA and CHA12microsphereswas
implanted in the defects, the amount of CHA12microspheres remaining in the defects (28
± 8% of the total defect area) was smaller than the HA microspheres (34 ± 10%) but the
difference was not significant (Fig. 5a, b). Several CHA12 microspheres were composed
of open (or incomplete) microspheres (Fig. 5a; arrows) in which a large segment of the
shell was missing. These open microspheres were filled with fibrous (soft) tissue. They
were presumably formed as a result of resorption in vivo. The number of open
microspheres normalized to the total number of microspheres was 27 ± 4% and 4 ± 4%,
respectively, for the CHA12 and HA groups. Higher magnification images (Fig. 5c, d) of
the boxed areas in Fig. 5a, b show a comparison of the open CHA12 microspheres and
the closed HA microspheres. While it is possible that the CHA12 microspheres could
have a lower strength than the HA microspheres, it appears unlikely that the higher
percent of open CHA12 microspheres was due to a lower strength. The calvarial defect is
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a non-loaded site and implantation of the microspheres required little force. Furthermore,
no broken pieces of CHA12 or HA microspheres were observed during preparation and
implantation of the microspheres.
H&E and von Kossa stained sections of the defects implanted with BMP2-loaded
CHA12 and HA microspheres for 12 weeks are shown in Fig. 6. Loading the
microspheres with BMP2 significantly enhanced their capacity to heal the defects. New
bone almost completely infiltrated the pore space between the microspheres and bridged
the ends of the defect. The percent new bone in the defects implanted with the BMP2loaded CHA12 microspheres (73 ± 9%) was significantly greater than the BMP2-loaded
HA microspheres (59±2%) (Fig. 7). The percent CHA12 microspheres remaining in the
defects at 12 weeks (7 ± 2% of the total defect area) was significantly lower than the HA
microspheres (21 ± 3%). The images of the H&E stained sections showed that some
marrow-like tissue was present in the defect space not occupied by new bone and residual
HA or CHA microspheres which is often a feature of bone regeneration stimulated by the
use of BMP2 [41−43].
4. Discussion
Hollow HA microspheres, with a high-surface-area mesoporous shell, can provide
a unique osteoconductive and bioactive carrier for the local delivery of therapeutics (such
as proteins) in bone repair [32,33]. However, HA with a nearly stoichiometric
composition has a slow resorption rate and its ability to remodel into bone is limited. The
results of the present study showed that partial substitution of the phosphate (PO 4)3− ions
with carbonate (CO3)2− ions in the HA enhanced the degradation or resorption rate of the
microspheres. The enhanced resorption rate of the carbonate-substituted hydroxyapatite
(CHA) microspheres did not enhance their capacity to regenerate bone in rat calvarial
defects when compared to the HA microspheres. Loading the HA and CHA microspheres
with BMP2 significantly improved bone regeneration. Defects implanted with the BMP2loaded CHA microspheres showed significantly higher new bone formation and lower
residual microsphere material at 12 weeks when compared to the BMP2-loaded HA
microspheres. These CHA microspheres, when loaded with clinically safe doses of
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BMP2, are promising implants for regenerating bone in non-loaded defects, such as
defects in the craniofacial region.
4.1. Properties of carbonate-substituted HA microspheres in vitro
The conversion of borate glass microspheres to hollow HA microspheres in an
aqueous phosphate solution near room temperature has been described in detail
previously [31]. As the glass degrades, the Ca2+ ions released from the glass react with
the (PO4)3− ions from the solution to form an amorphous calcium phosphate product on
the glass surface which subsequently crystallizes to HA. In the present study, varying
concentrations of (CO3)2− ions were added to the phosphate solution with the objective of
forming hollow microspheres composed of carbonate-substituted hydroxyapatite (CHA).
The results showed that hollow CHA microspheres were formed and that the amount of
carbonate substitution increased with higher amounts of (CO 3)2− ions in the starting
phosphate solution.
The amount of carbonate in human bone mineral is ~8 wt.% [44]. In the present
study, hollow HA microspheres, similar to the microspheres used in our previous studies
(which contained 2.1 wt.% carbonate) and hollow CHA microspheres with 8.6 and 12.4
wt.% carbonate were prepared and evaluated. It is likely that the higher amounts of
carbonate could be incorporated into the hollow HA microspheres but that was not
investigated. Substitution of Mg2+ and Sr2+ has also been shown to enhance the
degradation rate of HA [27−30] and it is expected that substitution of those ions could
also be achieved in the glass conversion route used in the present study.
The FTIR data indicated a B-type substitution in which (CO 3)2− ions substituted
for the (PO4)3− ions in the hydroxyapatite lattice [40] which is generally found in typical
biological HAs and synthetic HAs formed by precipitation from solution [39]. XRD
indicated that the carbonate substitution reduced the crystallinity of the HA. The major
hydroxyapatite peak in the XRD pattern showed a decrease in height and an increase in
half-width with increasing carbonate (Fig. 2a). SEM showed that the needle-like particle
morphology on the surface of the hollow HA microspheres changed to a more rounded
morphology on the surface of the CHA microspheres (Fig. 1), while the BET surface area
of the CHA microspheres were higher than the HA microspheres. A reduction in
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crystallinity and particle size has been observed previously for B-site substituted HA
[45,46].
The solubility of the hollow HA microspheres, as measured by the release of Ca 2+
ions in a potassium acetate buffer solution (pH = 5.0) at 37 °C increased with higher
carbonate content (Fig. 3a), which is compatible with the results of previous studies
[23,30,47]. As a constant surface area to volume ratio was used in the experiments, the
increase in solubility was presumably due to a reduction in crystallinity of the hollow
CHA microspheres. The amount of Ca2+ ions released from the CHA12 microspheres
into the buffer solution at 1 h was more than twice the value from the HA microspheres
(Fig. 3b). However, it was still only approximately half the value for a reference β-TCP
material with the same surface area.
Degradation of the hollow HA and CHA microspheres by osteoclast-like cells
was also observed in vitro, indicating that the microspheres were susceptible to both
solution-mediated and cell-mediated resorption. Previous studies showed that osteoclastic
degradation of HA was dependent on its composition, crystallinity and grain size [27−30].
Carbonate-substituted HAs with an amorphous structure or a fine grain size were found
to be more susceptible to degradation. In the present study, the hollow CHA
microspheres with 12 wt.% carbonate appeared to show more extensive degradation than
the HA microspheres by osteoclast-like cells but the amount of degradation could not be
readily quantitated. There was no observable difference in osteoclast adhesion to the
surface of the HA and CHA microspheres. While surface roughness and grain size can
influence cell adhesion [48,49], the osteoclasts (~50 μm) were much larger than
differences in the surface roughness, grain size and pore size of the microspheres (less
than a few tens of nanometers).
4.2. Resorption of hollow microspheres and bone regeneration in vivo
Resorption of the hollow HA and CHA12 microspheres without BMP2 in rat
calvarial defects was evaluated at 12 weeks postimplantation from the number of open
microspheres as a percentage of the total number of microspheres in the defect site.
Degradation of the microspheres was clearly visible in the form of open microspheres in
which a segment of the shell was missing (Fig. 5a, b). The percent open microspheres in
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the defect implanted with the CHA12 microspheres was significantly greater than the HA
group. Solution-mediated resorption of the hollow microspheres is expected to be
approximately homogeneous, leading to a gradual reduction in the shell thickness. In
comparison, osteoclastic resorption is expected to be more rapid, resulting in more rapid
degradation of the portions of the shell where the osteoclasts were attached. The
combination of solution-mediated and cell-mediated resorption presumably resulted in
the formation of the open microspheres within the twelve-week implantation period.
Bone regeneration in the defects implanted with the HA or CHA12 microspheres
(without BMP2) was limited, as observed in our previous study for HA microspheres
implanted in the same osseous defect model [33]. Loading the HA and CHA12
microspheres with BMP2 (1 µg per defect) significantly enhanced the capacity of both
groups to regenerate bone in the defects. The enhancement of bone regeneration in the
defects implanted with the BMP2-loaded HA microspheres is consistent with the results
of our previous study [33].
It was also found that the BMP2-loaded CHA12 microspheres had a faster
resorption rate than the HA microspheres with BMP2 and the CHA12 microspheres
without BMP2. The amount of residual BMP2-loaded CHA12 microspheres in the
defects at 12 weeks postimplantation (7± 2%) was significantly lower than the BMP2loaded HA microspheres (21 ± 3%) and the CHA12 microspheres without BMP2 (28 ±
8%). The faster resorption of the BMP2-loaded CHA12 microspheres (when compared to
the CHA12 microspheres without BMP2) could be explained in terms of the dual
function of BMP2 in controlling bone formation and bone resorption [50]. Briefly, the
Smad pathways activated by BMPs play a central role in BMP signaling by activating
osteoblastogenesis [51]. However, the Smad pathways activated by BMPs also activate
the bone resorption process which involves the expression of BMP antagonists such as
Noggin and Sclerostin (SOST), both of which are also secreted from osteoblasts [52].
SOST eventually enhances resorption by triggering receptor activator of nuclear factorkappa B ligand (RANKL)-osteoprotegerin pathway-induced osteoclastogenesis [53]. In
the present study, the enhancement of osteoclastic differentiation by BMP2 can lead to
faster degradation of the BMP2-loaded CHA12 microspheres in the rat calvarial defects
when compared to the CHA12 microspheres without BMP2.
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The percent new bone in the defects implanted with the BMP2-loaded CHA12
microspheres (73 ± 9%) was significantly greater than the BMP2-loaded HA
microspheres (59 ± 2%). Because of the faster degradation of the CHA12microspheres, a
larger amount of pore space was available for new bone infiltration, resulting in a
significantly larger amount of new bone in the defects implanted with the CHA12
microspheres.
The BMP2 dose used in the present study (1 µg per defect) was identical to the
dose used in our previous study [33] and within the range of doses used in previous
studies for the rat calvarial defect model [54−56]. It is also well below the dose found to
cause adverse biological effects in the same animal model [57]. However, the optimal
BMP2 dose for the CHA microspheres and the animal model used in the present study
was not investigated. Furthermore, the amount of carbonate in the CHA12 microspheres
evaluated in vitro (12.4 wt.%) was higher than the value (~8wt.%) in human bone. A
range of BMP2 doses and CHA microspheres with different carbonate content should be
investigated in future studies. In general, the results of the present study indicate that the
combination of carbonate-substituted hydroxyapatite microspheres and a clinically safe
dose of BMP2 could provide a promising system to stimulate bone regeneration and
enhance implant resorption in healing non-loaded bone defects.
5. Conclusions
Hollow hydroxyapatite (HA) microspheres, with a high-surface area mesoporous
shell, were prepared with controllable amounts of carbonate substitution (0−12 wt.%)
using a novel glass conversion route at 37 °C. Hollow HA microspheres with 12.4 wt.%
of carbonate (designated CHA12) showed a higher surface area (236 m 2 g−1) than hollow
HA microspheres prepared conventionally (179 m 2 g−1) and a faster degradation rate in a
potassium acetate buffer solution in vitro. When implanted for 12 weeks in rat calvarial
defects, the CHA12 and HA microspheres showed a limited capacity to regenerate bone
but the CHA12 microspheres resorbed faster than the HA microspheres. Loading the
microspheres with bone morphogenetic protein-2 (BMP2) (1 µg per defect) stimulated
bone regeneration and accelerated the resorption of the CHA12microspheres in the
defects. The amount of new bone in the defects implanted with the BMP2-loaded CHA12
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microspheres was significantly greater than the HA microspheres while the amount of
residual CHA12 microspheres was significantly lower than the HA microspheres. The
combination of these carbonate substituted HA microspheres with clinically safe doses of
BMP2 could provide promising implants for healing non-loaded bone defects.
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Fig. 1. SEM images of the cross section of a hollow HA microsphere (a, b) and higher
magnification images showing differences in surface morphology between the hollow
HA and CHA12 microspheres (c, d).

Fig. 2. (a) X-ray diffraction patterns and (b) FTIR spectra of the hollow HA, CHA9 and
CHA12 microspheres. The pattern of a reference hydroxyapatite (HA JCPDS 72-1243) is
also shown in (a).
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Fig. 3. (a) Cumulative amount of Ca2+ ion released from hollow HA, CHA9, and CHA12
microspheres into 0.1 M potassium acetate buffer solution (pH = 5.0; 37 °C) as a function
of immersion time. (b) Amount of Ca2+ ions released from the three groups of
microspheres after 1 h in the buffer solution. For comparison, the release of Ca 2+ ions
from a β-TCP reference material is also shown. (*significant difference between groups;
p < 0.05).

Fig. 4. SEM images of the surface of the HA, CHA9 and CHA12 microspheres after
incubation with TIB-71 cells with added RANKL for 1 week (a1−3), and after the cells
had been rinsed off (b1−3). (C: cells; P: pitted area after removal of cells).
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Fig. 5. Transmitted light images of (a, b) H&E stained sections of rat calvarial defects
implanted with hollow CHA12 and HA microspheres without BMP2 at 12 weeks
postimplantation; (c, d) higher magnification images of the boxed areas in a, b.
(Arrowheads: edges of host bone; arrows: open microspheres).
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Fig. 6. Transmitted light images of (a, b) von Kossa and (c, d) H&E stained sections of
rat calvarial defects implanted with hollow CHA12 and HA microspheres loaded with
BMP2 at 12 weeks postimplantation; (e, f) higher magnification images of the boxed
areas in c, d. (Arrowheads: edges of host bone).
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Fig. 7. New bone and residual amount of microspheres, as a percentage of the total defect
area, in rat calvarial defects implanted with CHA12 and HA microspheres loaded with
BMP2 at 12 weeks postimplantation. (*significant difference between groups; p < 0.05)

Table I. Characteristics of hollow hydroxyapatite (HA) and carbonate-substituted
hydroxyapatite (CHA) microspheres prepared by converting borate glass microspheres
(150−250 µm) in 0.02 M K2HPO4 solution containing different concentrations of KHCO 3
at 37 C. Data for commercial β-TCP granules used as the control group are included for
reference.
Microsphere

KHCO3

CO3 content

Surface area

Average

Microsphere

designation

concentration

of

of

pore size of

diameter

(M) in

microspheres

microspheres

shell (nm)

(µm)

solution

(wt. %)

(m2g1)

0

2.1a

179

11

150−250

CHA9

0.135

8.6

233

8
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CHA12

0.27

12.4

236

7
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β-TCP
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b
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ABSTRACT
There is a clinical need for synthetic bioactive materials that can reliably repair
intercalary skeletal tissue loss in load-bearing bones. Bioactive glasses have been
investigated as one such material but their mechanical response has been a concern.
Previously, we created bioactive silicate glass (13–93) scaffolds with a uniform grid-like
microstructure which showed a compressive strength comparable to human cortical bone
but a much lower flexural strength. In the present study, finite element modeling (FEM)
was used to re-design the scaffold microstructure to improve its flexural strength without
significantly lowering its compressive strength and ability to support bone infiltration in
vivo. Then scaffolds with the requisite microstructures were created by a robotic
deposition method and tested in four-point bending and compression to validate the FEM
simulations. In general, the data validated the predictions of the FEM simulations.
Scaffolds with a porosity gradient, composed of a less porous outer region and a more
porous inner region, showed a flexural strength (34 ± 5 MPa) that was more than twice
the value for the uniform grid-like microstructure (15 ± 5 MPa) and a higher compressive
strength (88 ± 20 MPa) than the grid-like microstructure (72 ± 10 MPa). Upon
implantation of the scaffolds for 12 weeks in rat calvarial defects in vivo, the amount of
new bone that infiltrated the pore space of the scaffolds with the porosity gradient (37 ±
16%) was similar to that for the grid-like scaffolds (35 ± 6%). These scaffolds with a
porosity gradient that better mimics the microstructure of human long bone could provide
more reliable implants for structural bone repair.
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1. Introduction
The repair of large structural bone defects such as segmental defects in the long
bones of the limbs is a challenging clinical problem [1]. In comparison, small, contained
bone defects are repairable with commercially available osteoconductive and
osteoinductive filler materials [2,3]. To treat structural bone loss, clinicians use bone
allografts, autografts and porous metals. These materials are limited by cost, availability,
durability, infection risk, donor site morbidity, and uncertain healing. Consequently, there
is a clinical need for synthetic bioactive implants that can reliably repair intercalary
skeletal tissue loss in load-bearing bones.
Bioactive glasses have been investigated as one such material since they are
osteoconductive, convert to hydroxyapatite in vivo, heal readily to host bone and soft
tissues, and they are amenable to fabrication into porous three-dimensional (3D)
architectures [4–8]. In the form of particles and weak scaffolds, bioactive silicate glasses
such as the glasses designated 45S5 and 13–93 are approved by the Food and Drug
Administration (FDA) for in vivo use, and they are used clinically to reconstitute nonstructural bone defects [8].
Advances in rapid prototyping techniques (also referred to as solid freeform
fabrication or additive manufacturing) have resulted in more innovative design and
unprecedented control of scaffold microstructures [9]. Recent studies have shown the
ability to create porous 3D scaffolds of bioactive silicate glasses (13–93 and 6P53B) with
compressive strength comparable to human cortical bone using rapid prototyping
methods [10–15]. Our previous study showed that 13–93 bioactive glass scaffolds,
created with a uniform grid-like microstructure by robocasting, had a compressive
strength (86 ± 9 MPa) and an elastic modulus (13 ± 2 MPa) comparable to the human
cortical bone [13]. In comparison, the flexural strength of the scaffolds (11 ± 3 MPa) was
much lower than cortical bone (~100 MPa). While those scaffolds showed the capacity to
heal critical size segmental defects in rat femurs [16], improvement in their flexural
strength could alleviate concerns about their mechanical reliability in vivo.
Finite element modeling (FEM) has been widely used to analyze the mechanical
response of biomaterials [17–20]. In a recent study, FEM was used to simulate the
mechanical response of models composed of hydroxyapatite or beta-tricalcium phosphate
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with a cubic geometry and uniform grid-like structure [17]. Regions of the structure with
the highest local stress were determined under loading in compression, tension or shear
and used to predict the strength of scaffolds with the same grid-like microstructure.
Scaffolds created by a robocasting method were tested in compression to validate the
FEM simulations. However, the FEM analysis and mechanical testing were limited to a
cubic geometry and a uniform grid-like structure. The mechanical response of alternative
geometries relevant to bending (flexure), an important loading mode in structural bone,
and alternative structures relevant to the non-uniform microstructure of human long
bones were not analyzed or tested.
The cross section of long bones of the limbs has a non-uniform microstructure,
composed of a less porous outer region of cortical bone (porosity = 5–10%) and a more
porous inner region of trabecular bone (porosity = 50–90%). As outlined above, our
previous studies showed that a uniform grid-like microstructure provided bioactive glass
(13–93) scaffolds with promising compressive strength and capacity to support bone
infiltration but a flexural strength that was much lower than cortical bone [13,21,22].
Because the uniform grid-like microstructure is limited in its ability to mimic the
microstructure of human long bones, an investigation of alternative microstructures is
warranted. When compared to an approach based on trial-and-error experiments, FEM
simulations could provide a more efficient approach to predict the mechanical response
of a variety of alternative microstructures.
The objective of the present study was to re-design the uniform grid-like
microstructure used in our previous studies and determine whether alternative
microstructures can impart higher flexural strength to 13–93 glass scaffolds without
compromising their compressive strength and ability to support bone infiltration. FEM
was used to simulate the mechanical response in flexure and compression for models
with a variety of structures. Then scaffolds with the optimal microstructures predicted by
FEM were created by robocasting and tested in four-point bending and in compression to
validate the predictions of the FEM simulations. Scaffolds with the optimal
microstructures were also implanted for 12 weeks in rat calvarial defects to evaluate their
ability to support bone infiltration in vivo.
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2. Materials and methods
2.1 Design of scaffold architecture
A uniform grid-like microstructure, in which the glass filaments in adjacent layers
were arranged at right angles with reference to the x and y axes, was used as the reference
structure and our approach was to modify the spatial arrangement of the filaments. The
diameter of the glass filaments (330 μm) used in the FEM simulations was the same as
the filaments in the uniform grid-like scaffolds created by robocasting in our previous
studies [13,16,21,22]. In view of our interest in improving the flexural strength of the
bioactive glass scaffolds while maintaining the promising compressive strength, the
flexural mechanical response of the structures was analyzed first. Then the response of
selected structures was analyzed in compression.
For the FEM analysis in flexure, a beam was selected as the macroscopic external
shape of the physical model because this geometry is commonly used in the measurement
of flexural strength by four-point bending. The external dimensions of the model (Fig. 1)
were selected to avoid the use of excessive computing power and time. However, the
dimensions of the model were still large enough to allow the use of enough layers to
create a porosity gradient in the structure and to create scaffolds with similar dimensions
for experimental four-point bending tests.
Each model was composed of 13 alternating orthogonal layers of parallel
filaments. The length and angle of the filaments and the spacing between the parallel
filaments were defined for each layer. With different arrangements of the filaments in
each layer, 11 different 3D models were designed (Table I). The models all had the same
external dimensions. Ten models were composed of 7 layers of short (S) filaments along
the x axis and 6 layers of long (L) filaments along the y axis. The assignments L1 to L4
were used to describe the arrangement of the long filaments while S1 to S3were used
describe the arrangement of the short filaments. For example, L3S1 designated the model
in which the long filaments had the L3 arrangement and the short filaments, orthogonal to
the long filaments, had the S1 arrangement. In the eleventh model, designated S45°, the
filaments in the adjacent layers were arranged at 45 o to the x and y axes. In this model,
the 13 alternating orthogonal layers consisted 4 layers each with a lower porosity on the
top and the bottom of the model and 5 layers with a higher porosity in the middle. Except
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for the L4S1 model, all the models had the same porosity (~43% as determined from the
models by the software). For the L4S1 model, additional long filaments were added to the
two outermost layers of the L1S1 structure, resulting in a lower porosity (~33%). The
center-to-center distance between adjacent filaments in each layer of the models is given
in Table II.
Based on the results of FEM simulations in flexure, 3 models were selected for
analysis in compression. Models with the L3S1 and L4S1 structures were selected
because the FEM simulations showed that these structures had a higher flexural strength
than the uniform grid-like L1S1 structure. In addition, the uniform grid-like L1S1
structure was analyzed for comparison. Each model was composed of 19 alternating
orthogonal layers of parallel filaments (Fig. 2). All three models had the same external
shape (a cube with each side equal to ~5 mm). The glass filaments were identical to those
described for the flexural analysis. The cross sections of the structures (xy plane) were
identical to the L1S1, L3S1 and L4S1 models and the load was applied in the z direction.
2.2 Finite element simulations
Finite element simulations were carried out using ABAQUS/CAE 6.12-1 software
(Dassault Sytemes Simulia Corp., Providence, RI). All 11 models in Table I were
analyzed in flexure while the 3 models in Fig. 2 were analyzed in compression. The
filaments in all the models were assumed to be composed of a dense homogeneous
material with a Young's modulus of 70 GPa and a Poisson's ratio of 0.25, values which
are comparable to those of a silicate glass [23].
For the simulations in flexural loading, 4 rigid cylinders with a diameter of 2.0
mm were generated to simulate the fixture used in the four-point bending test (Fig. 3).
The two upper cylinders, each 5 mm from the midline, served as the inner span, while the
two lower cylinders, 10 mm from the midline, served as the outer span. The cylinders
were in contact with the model from the beginning of the simulations. Furthermore, the
contact between the cylinders and the model was assumed to be hard (no interpenetration
between the materials) and frictionless. For the simulations in compression, two rigid
planes were generated to simulate the platens used in a compression test. The planes were
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in contact with the scaffold from the beginning of the simulation, and the contact between
the planes and the scaffold was also assumed to be hard and frictionless.
The models were partitioned into several parts in order to improve the meshing
and apply the proper boundary conditions. The FEM models were discretized with an
approximate mesh size of 120 μm, and quadratic tetrahedral elements were used. For the
simulations in flexural loading, each of the models with the same porosity contained
~1.4×106 elements, while L4S1 contained ~1.7 × 106 elements. Different element sizes
were used to test the convergence of the FEM simulations. Smaller element sizes
produced approximately the same results but they required a much longer time to
complete the simulation. The element size used in this study provided a good balance
between computing time and the results. The middle of the cross section perpendicular to
x axis was fixed at the x axis direction (U1=0) to prevent the scaffold from sliding in the
x axis direction, while the middle of the cross section perpendicular to y axis was fixed at
the y axis direction (U2 = 0) to prevent sliding in the y axis direction during bending. The
two lower cylinders of the fixture were fixed in all directions (U1=U2=U3=0) and an
evenly distributed load of 100 N was applied to the two upper cylinders through a static,
general step with default time duration of 1 s.
For the simulations in compression, the L1S1 and L3S1 models contained ~0.4 ×
106 elements, while L4S1 model contained ~0.5 × 106 elements. The middle of the cross
section perpendicular to the x axis was fixed at the x axis direction (U1 = 0), while the
middle of the cross section perpendicular to y axis was fixed at the y axis direction
(U2=0). The bottom plane was fixed in all directions (U1=U2=U3=0) and an evenly
distributed load of 1500 N was applied to the top plane through a static, general step with
default time duration of 1 s. The load was applied in the z direction (Fig. 2) which
corresponds to the loading mode of an actual scaffold implanted in a segmental defect in
the long bones of the limbs.
A desktop computer with 16 CPU cores and 128 GB of RAM were used for the
simulations. A typical CPU time to complete a simulation was ~4 h and ~1 h,
respectively, for bending and compression. As a brittle material, glass can withstand
much higher stresses in compression than in tension. Consequently, the highest tensile
stress within the inner span of the model was used as the primary parameter in the
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flexural strength analysis. The compressive strength analysis focused on locating the
highest tensile stress through the whole scaffold.
2.3 Experimental four-point bending and compression tests
The scaffolds (L1S1) with a uniform grid-like microstructure were fabricated
using the same method described in detail in our previous study [13]. Briefly, the asreceived 13–93 glass (Mo-Sci Corp., Rolla, MO) was ground to form particles (~1 μm),
mixed with a 20 wt% Pluronic-127 binder solution to form a paste (40 vol% glass
particles) and extruded using a robocasting machine (RoboCAD 3.0; 3-D Inks, Stillwater,
OK). After drying at room temperature, the scaffolds were heated in O 2 at a rate of 0.5 °C
min−1 to 600 °C to burn out the processing additives and sintered for 1 h at 700 °C
(heating rate = 5 °C min−1) to densify the glass filaments.
Based on the results of the FEM simulations, 5 groups of scaffolds with the
designation L1S3, L3S3, L3S1, L4S1 and S45° were also created using this method for
mechanical testing in flexure. Three groups of scaffolds, with microstructures
corresponding to L1S1, L3S1 and L4S1 designations, were created using the same
method for testing in compression. The porosity of the fabricated scaffolds, measured
using the Archimedes method, was the same as the porosity of the models. The scaffolds
were stored in a desiccator prior to testing to avoid degradation by water vapor in the
atmosphere and they were tested in the as fabricated state (without any machining) to
avoid introducing strength-limiting flaws due to machining.
Flexural testing of the scaffolds in four-point bending was performed on a fully
articulated fixture (outer span = 20 mm; inner span =10 mm) at a crosshead speed of 0.2
mm min−1 using a 2 kN load cell. The stress was applied in the z direction (the same
direction used in the FEM simulations). Ten samples of each group with the same
dimensions as the models (23.0mm× 4.7mm× 3.2mm) were tested according to the
procedure described in ASTM C1674-11 and the flexural strength was determined from
the equation

 

3 PL
4bd 2

where P is the applied load, L is the outer span, b is the sample width, and d is the
thickness of the sample.

(1)
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The Weibull modulus of the scaffolds with the L3S1 and L4S1 architectures was
determined by analyzing the flexural strength of thirty samples. According to ASTM
C1239-07, the flexural strength data were fitted with the equation
 1
ln ln 
 1  Pf



 
  m ln 

 0 


(2)

where Pf is the probability of failure at a stress  , the normalizing stress  0 is the
Weibull scale parameter determined from the intercept of the fit to the data, and the
Weibull modulus m is the slope of the straight line fit. The value  0 is also the stress at
which the probability of failure is 63%. The value of Pf was determined using the
equation
Pf 

i  0.5
n

(3)

where n is the total number of specimens tested and i is the specimen rank in ascending
order of failure stresses.
After testing, the fractured surfaces of the samples were coated with Au/Pd and
examined in a scanning electron microscope, SEM (S-4700; Hitachi, Tokyo, Japan). The
fracture morphology, particularly of the bottom and top filaments of the scaffolds,
subjected to tensile and compressive stresses in the four-point bending test, was
examined.
Testing in compression was performed between two metal platens at a cross-head
speed of 0.5 mm min-1 using a 10 kN load cell. Deformation of the sample was
determined from the movement of the crosshead. The load was applied along the z axis,
the same direction used in the simulations. Ten samples in each group, with the same
dimensions as the models (5 mm  5 mm  5 mm), were tested.
2.4 Animal surgery
Scaffolds with the shape of discs (4.6 mm in diameter  1.5 mm) and
microstructures corresponding to the L1S1, L3S1 and L4S1 designations were created
using the same robocasting method described earlier for implantation in rat calvarial
defects in vivo (Fig. 4). The circumferential area of the scaffold in contact with host
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calvarial bone corresponded to the cross-section that would be in contact with host bone
in a segmental defect of the long bones of the limbs. Each scaffold was composed of 7
layers of orthogonal filaments which resulted in a thickness that was approximately equal
to the thickness of the calvarial defect (1.5 mm).
All animal experimental procedures were approved by the Animal Care and Use
Committee, Missouri University of Science and Technology, in compliance with the NIH
Guide for Care and Use of Laboratory Animals (1985). Eleven Sprague Dawley rats (3
months old; 350 ± 50 g; Harlan Laboratories Inc., USA) were maintained in the animal
facility for 2 weeks to become acclimated to diet, water and housing under a 12 h/12 h
light/dark cycle. The rats were anesthetized with an intramuscularly injected mixture of
ketamine and xylazine (1.5 µl kg1). The surgical area was shaved, scrubbed with 70%
ethanol and iodine and draped. With sterile instruments and an aseptic technique, a
cranial skin incision was sharply made in an anterior to posterior direction along the
midline. The subcutaneous tissue, musculature and periosteum were dissected and
reflected to expose the calvarium. Bilateral full-thickness defects 4.6 mm in diameter
were created in the central area of each parietal bone using a phosphate-buffered saline
(PBS)-cooled trephine drill without disturbing the dura mater. The sites were constantly
irrigated with sterile PBS to prevent overheating of the bone margins and to remove the
bone debris. The bilateral defects were randomly implanted with 7 replicates per group
(L1S1, L3S1 and L4S1). The number of replicates per group (n = 7) was based on our
previous studies [21]. The periosteum and skin were repositioned and closed using
wound clips. The animals were given a dose of ketoprofen (3 mg per kg mass of the
animal) intramuscularly and 0.2 ml penicillin subcutaneously post-surgery, and they were
monitored daily for the condition of the surgical wound, food intake, activity and clinical
signs of infection. At 12 weeks, the animals were sacrificed by CO 2 inhalation and the
calvarial defects with surrounding bone and soft tissue were harvested for subsequent
evaluation.
2.5 Histology and histomorphometric analysis
The harvested calvarial samples were fixed in 10% formaldehyde for 5 days,
washed with deionized water and then cut in half. Half of each sample was for paraffin
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embedding while the other half was for polymethyl methacrylate (PMMA) embedding.
The samples for paraffin embedding were de-siliconized by immersion for 2 h in 10%
hydrofluoric acid, decalcified in 14% ethylenediaminetetraacetic acid (EDTA) for 4
weeks, dehydrated in a graded series of ethanol and embedded in paraffin using routine
histological techniques. Then the samples were sectioned to 5 µm using a microtome and
stained with hematoxylin and eosin (H&E). The undecalcified samples were dehydrated
in a graded series of ethanol and embedded in PMMA. Sections were affixed to acrylic
slides, ground down to 40 µm using a surface grinder (EXAKT 400CS, Norderstedt,
Germany) and stained using the von Kossa method. Transmitted light images of the
stained sections were taken with an Olympus BX 50 microscope connected to a CCD
camera (DP70, Olympus, Japan).
Histomorphometric analysis was carried out using optical images of the stained
sections and the ImageJ software (National Institutes of Health, USA). One section across
the diameter of each defect was analyzed. The percent new bone formed in the defects
was evaluated from the H&E stained sections. The entire defect area was determined as
the area between the two defect margins, including the entire glass scaffold and the
tissues within. The available pore area within the scaffold was determined by subtracting
the area of the bioactive glass scaffold from the total defect area. The newly formed bone
were then outlined and measured. The von Kossa-positive area was determined from the
von Kossa stained sections, which yielded the combined amount of mineralized bone and
hydroxyapatite converted from the glass as both bound the silver nitrate.
2.6 Statistical analysis
The data are presented as a mean ± standard deviation (SD). Analysis for
differences in the maximum applied load, flexural strength, compressive strength, new
bone area and mineralization between groups was performed using one-way analysis of
variance (ANOVA) with Tukey’s post hoc test. Differences were considered significant
for p < 0.05.
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3. Results
3.1 Finite element simulation of four-point bending
The deformation of the L1S1 model (uniform grid-like structure) in four-point
bending is shown in Fig. 5, with a scale factor of 30 (i.e., the deformation has been
magnified 30 times for ease of observation). Similar deformation profiles were found for
other structures. According to the maximum principal stress theory (Tresca), failure will
occur when the maximum principal stress in a system reaches the value of the maximum
stress at the elastic limit in simple tension, which is approximately correct for brittle
materials such as glass. Consequently, the maximum principal stress (S, Max. Principal
(Abs.)) was evaluated and the results are shown in color as represented by the scale in Fig.
5. The top layers of the scaffold had a negative tensile stress because they were in
compression. The highest tensile stress was in the bottom layers and it decreased with
distance above the bottom of the model. Particular attention was paid to differences in the
magnitude and distribution of the stress in the bottom layers of the various models.
The magnitude and distribution of the tensile stress near the middle of the two or
three bottom layers of the L1S1, L1S3, L3S1 and L4S1 models are shown in Fig. 6. For
the L1S1 model (Fig. 6a), corresponding to the uniform grid-like microstructure used in
our previous experimental studies [13,16,21,22], the tensile stress was generally uniform
over most of the area of the long filaments (green color). However, a higher tensile stress
(weak yellow color) was found in the regions of the long filaments near the interfaces
between the long filaments and the short filaments in the adjacent layer. When compared
to the L1S1 model, under the same applied load, the stress in the long filaments of the
L1S3 model showed approximately the same distribution but the magnitude of the tensile
stress was several times higher (Fig. 6b). In comparison, the tensile stress in the
filaments of the L3S1 model (Fig. 6c) was lower than the L1S1 model while the L4S1
model (Fig. 6d) showed even smaller tensile stresses in the filaments than the L3S1
model.
Based on the color scheme and the stress scale (Fig. 6), the highest tensile stress
in the middle region of the bottom layers are shown in Fig. 7 for the different models
analyzed. For the nine LiSi models (i = 13) which have the same porosity, redistributing
the short filaments from the middle region of the model to the top and bottom layers
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resulted in a higher tensile stress. For the same number of long filaments, the highest
tensile stress was in the order S1 < S2 < S3. Redistributing the long filaments from the
middle region to the top and bottom layers of the model resulted in a smaller maximum
tensile stress in the model, according to the order L1 > L2 > L3. For the L4S1 model
which had a lower porosity due to a larger number of long filaments, the highest tensile
stress in the bottom filaments was even lower than the L3S1 model. The tensile stress in
the bottom filaments of the L3S1 and L4S1 models were 25% and 44% lower,
respectively, than the L1S1 model. In comparison, the S45 model (filaments at 45 to
the x and y axes) showed a tensile stress in the bottom filaments that was 210% higher
than the L1S1 model. Overall, for the same applied load, the L4S1 and L3S1 models
showed the lowest tensile stress in the bottom filaments while the L1S3 model showed
the highest tensile stress for the ten LiSi models analyzed. The S45 model showed the
highest tensile stress among all eleven models.
3.2 Measured flexural strength of scaffolds in four-point bending
The cross sections of the as-fabricated scaffolds with the L1S1, L3S1 and L4S1
microstructures, created using robocasting, are shown in Fig. 8 in the plane perpendicular
to the long filaments. In general, the microstructures of the as-fabricated scaffolds
corresponded well to the model structures used in the FEM analysis. For the scaffold with
the L3S1 microstructure (Fig. 8b), some sagging of the short glass filaments right above
the layers with the smallest number of long filaments (the layers with the largest spacing
between the long filaments) was observed. In comparison, no sagging was observed in
the L1S1 and L4S1 microstructures, presumably because the long filaments in all the
layers were close enough to provide adequate support for the short layers.
In the four-point bending test, the maximum load at failure for the scaffolds with
the L1S3, L3S3, L1S1, L3S1, L4S1 and S45 microstructures are summarized in Fig. 9a
while the flexural strength, determined using Equation 1, are shown in Fig. 9b. When
compared to the uniform grid-like (L1S1) microstructure studied previously (flexural
strength = 15 ± 5 MPa), the L1S3 microstructure showed the lowest flexural strength (10
± 4 MPa) while the flexural strength of the L3S3 microstructure (16 ± 4 MPa) was not
significantly different. In comparison, the L3S1 microstructure showed the highest
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flexural strength (22 ± 3 MPa) among the microstructures with same porosity (43%),
and it was significantly higher (~50% higher) than the L1S1 microstructure. The flexural
strength of the L4S1 microstructure, with a lower porosity (33%), showed the highest
flexural strength (34 ± 5 MPa) which was also significantly higher (~130% higher) than
the L1S1 architecture. The flexural strength of the S45 microstructure (14 ± 3 MPa) was
not significantly different from L1S1 and L3S3 microstructures.
Figure 10a, b shows Weibull plots of the flexural strength data for scaffolds with
the L3S1 and L4S1 microstructures. The straight line fit to the data was obtained using a
least-squares method. The data points within most of the stress range were well fitted by
the straight line (R2 = 0.95 or 0.96) but there was some deviation at the lowest and
highest stress values. The Weibull modulus m and the normalizing stress  0 were
determined from the slope and intercept of the straight line fit. The results showed that m
= 9 and  0 = 23 MPa for the LS31 microstructure, and m = 8 and  0 = 36 MPa for the
L4S1 microstructure. In comparison, four-point bending tests in our previous study
showed that m = 6 and  0 = 12 MPa for the uniform grid-like scaffolds with the L1S1
microstructure [13].
SEM images of fractured surfaces of the scaffolds with the L3S1 and L4S1
microstructures from the four-point bending tests are shown in Fig. 11. Features such as
hackle region, mist region, smooth mirror region and arrest lines [24], similar to those
observed previously for the L1S1 microstructure [13], were found on the fractured
surface of both samples. The origin of failure of some glass filaments was determined
using fractography guidelines. By outlining the mist region with a circle, the failure
origin is commonly at the center of the circle, while the hackle lines commonly point to
the origin. However, it was difficult to locate the initial failure origin of the scaffold itself.
Cantilever curls observed near the top region of the fractured surface often indicate
regions of compression in flexural testing of brittle solids [24].
3.3 Finite element simulations and testing in compression
For each of the three models (L1S1, L3S1 and L4S1 structures), the filaments in
all the layers in the xy plane showed a similar color distribution when subjected to the
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same applied load, indicating no discernible difference in the stress in each layer (Fig.
12a,b,c). For all three groups, colors (yellow to red) representing higher tensile stress
were found in the regions where the filaments parallel to the x direction were bonded to
the filaments in the z direction (Fig. 12a1, b1, c1). The models with the L1S1 and L3S1
structures did not show any observable difference in color (stress) in those regions
whereas the L4S1 showed colors (green to yellow) that corresponded to a smaller tensile
stress.
In general, the measured compressive strengths of the scaffolds (L1S1, L3S1 and
L4S1 microstructures) were compatible with the predictions of the FEM simulations. The
compressive strength of the scaffolds with the L3S1 microstructure (71 ± 20 MPa) was
approximately equal to that for the scaffolds with the uniform grid-like (L1S1)
microstructure (72 ± 10 MPa) (Fig. 13). In comparison, the compressive strength of the
scaffolds with the L4S1 microstructure (88 ± 20 MPa) was 22% higher. The higher
compressive strength observed for the scaffold with the L4S1 microstructure was
presumably due to its lower porosity (33% compared to 43% for the L1S1 and L3S1
microstructures). (See Fig. 14.)
3.4 Assessment of bone regeneration
Transmitted light images of H&E stained sections of the rat calvarial defects
implanted for 12 weeks with the three groups of scaffolds having the L1S1, L3S1 and
L4S1 microstructure are shown in Fig. 14a1,b1,c1. New bone infiltrated all three groups
of scaffolds, into the edges (periphery) adjacent to the host bone and into the pores,
indicating good integration of the scaffolds with the surrounding calvarial bone
regardless of the difference in microstructure. The amount of new bone that infiltrated the
three groups of scaffolds are shown separately in Fig. 15 as a percentage of the total
defect area and the total pore area of the scaffolds. The amount of new bone that
infiltrated the scaffold with the uniform grid-like microstructure (L1S1) was 15 ± 3 %
based on the total defect area. This value is not significantly different from the values
found in our previous studies for scaffolds with the same microstructure and for the same
animal model [21, 22]. In comparison, the amount of new bone that infiltrated the
scaffolds with the L3S1 and L4S1 microstructures was 19 ± 5 % and 9 ± 5 % respectively,
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respectively. However, the differences among the three groups were not statistically
significant. Because the scaffolds had different microstructures, the amount of new bone
as percentage of the total pore area was also evaluated. The values were 35 ± 6 %, 36 ±
10 % and 37 ± 16 %, respectively, for scaffolds with the L1S1, L3S1 and L4S1 groups.
These values show that based on the available pore space, there was no difference in the
capacity of the groups of scaffolds to support bone infiltration.
Transmitted light images of von Kossa stained sections of the rat calvarial defects
implanted for 12 weeks with the three groups of scaffolds are shown in Fig. 14a2,b2,c2.
The von Kossa staining detects a combination of bone and glass converted to
hydroxyapatite (phosphate material). The total von Kossa positive area, evaluated as a
percentage of the total defect area, was 37 ± 7 %, 36 ± 5 % and 32 ± 4 %, respectively,
for scaffolds with the L1S1, L3S1 and L4S1 microstructures (Fig. 15). There was no
significant difference among the values. Subtracting the percentage of new bone (based
on the total defect area), the amount of the scaffold that converted to hydroxyapatite in
the twelve-week implantation period was 22%, 17% and 23%, respectively, for the
scaffolds with the L1S1, L3S1 and L4S1 microstructures.
4. Discussion
Strong porous scaffolds of silicate 13-93 bioactive glass are showing promise as a
synthetic biomaterial in healing structural bone defects. Scaffolds with a uniform gridlike microstructure and a compressive strength comparable to human cortical bone have
shown the capacity to heal critical size segmental defects in rat femurs [16]. However, the
low flexural strength of those scaffolds (11 ± 3 MPa) found in a previous study [13] is a
concern because bending is an important loading mode in structural bone. In the present
study, we used a combined approach consisting of FEM simulations and experimental
testing to identify alternative microstructures with improved flexural strength.
Redistribution of the glass filaments in the uniform grid-like microstructure to form a
porosity gradient that better mimics human long bones resulted in scaffolds with
significantly higher flexural strength. Furthermore, the scaffolds with the gradient
porosity retained the high compressive strength of the uniform grid-like scaffolds and
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their ability to support bone infiltration. These scaffolds could provide more reliable
bioactive glass implants for structural bone repair.
4.1 FEM simulations
The FEM analysis in the present study focused on simulating the flexural
mechanical response of porous 3D scaffolds with microstructures based on a grid-like
arrangement of glass filaments. A grid-like arrangement was used because our previous
experiments showed that scaffolds composed of a uniform grid-like microstructure had
the requisite compressive strength (comparable to cortical bone) as well as the capacity to
support bone infiltration in vivo. However, the flexural strength of the scaffolds was
much lower than cortical bone. One objective was to determine whether a redistribution
or rearrangement of the filaments in the grid-like microstructure could lead to an
improvement in the flexural strength. FEM provided an efficient approach to simulate the
mechanical response of a variety of microstructures.
The uniform grid-like model used as a reference was composed of filaments
arranged orthogonally in the x and y directions. Maintaining the grid-like arrangement
and total porosity but rearranging the filaments orthogonally at 45 to the x and y
directions (the S45 model) resulted in higher tensile stresses in the bottom layers of the
model. Consequently, the simulations focused on retaining the arrangement of the
filaments in the x and y direction but redistributing the filaments to form a gradient
microstructure. The simulations served as a guide for comparing the mechanical response
of a variety of models and reduced the time required in an approach based solely on
experimental trial-and-error.
In a four-point bending test, the bottom layer in the middle part between the inner
span is subjected to the highest tensile stress. As the structure is assumed to fail when the
stress exceeds the tensile strength of the glass filaments, the stress in that region of the
model was a major consideration in the simulations. For models with the same porosity
(43%), the simulations showed that redistributing some long filaments from the two
interior layers to the top and bottom layers resulted in a lower tensile stress in the long
filaments of the lowest layer (where the tensile stress is greatest). The tensile stress
generated in the L2S1 and L3S1 models was lower (by 6% and 25%, respectively) when
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compared to the L1S1 model. As the structure is assumed to fail when the stress exceeded
the tensile strength of the glass filaments, a reduction in the tensile stress is indicative of
an increase in the flexural strength for identical systems.
By taking the L3S1 model and adding long filaments to the second layer from the
top and bottom also, thereby increasing the total number of long filaments and the density
of the model, a further reduction in the tensile stress of the bottom layers was achieved.
The tensile stress in the bottom layer of the L4S1 model was 44% lower than the L1S1
model. The tensile stress in the bottom layer is distributed among a larger number of
filaments (or a denser region), resulting in a lower stress in the individual filaments.
Redistributing some of the short filaments from the middle region of the model to
the top and bottom layers resulted in an increase in the tensile stress of the bottom layer.
As the short filaments are parallel to the cylinders that apply the load to the model, a
larger number of short filaments created more interfaces with the long filaments. The
decrease in the flexural strength might be related to the change in the projected area of
the applied load on the short filaments and the number of interfaces between the short
and long filaments in the bottom layer.
Some assumptions in the FEM analysis are idealized and, consequently, they
differed from the actual experimental system. In the FEM analysis, the model assumed
fully dense filaments without flaws and ideal bonding between the filaments in adjacent
layers so that the simulations could focus on the effects of the structure on the flexural
mechanical response. In practice, glasses and other brittle materials commonly contain
flaws such as pores and microcracks which have a major effect on their mechanical
response (particularly in flexural or tensile loading). Another factor is the strain rate (or
crosshead speed) used in the four-point bending test. The FEM simulations assumed a
more or less static condition (the load increased from 0 to the defined value in 1 s, the
default time period for a static general step in the ABAQUS software). In comparison, the
experimental four-point bending test is more dynamic. The load is applied to the
specimen at a constant speed according to ASTM guidelines (0.2 mm min -1 in the present
study). During the slow movement of the crosshead, microcracks and other flaws have
enough time to grow. As the glass filaments were assumed to be free from flaws in the
model, the simulation of a dynamic system was not necessary in the present study. The
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simulation of a dynamic system would also require a considerable increase in computing
power and time.
4.2 Measured flexural strength of scaffolds and validation of FEM simulations
The structures analyzed in the FEM analysis were generally well replicated by the
microstructures of the scaffolds fabricated by robocasting (Fig. 6). The scaffolds had a
well-controlled microstructure but there was some sagging of the short filaments in the
middle layers of a few scaffolds that contained the smallest number of long filaments (Fig.
6b). The long filaments appeared to be too widely spaced to provide sufficient support for
the short filaments during the robocasting process. The glass filaments were almost fully
dense, as assumed in the models, but a few small pores were apparent in the cross section
of the filaments. SEM examination did not show large flaws in the glass filaments, such
as large pores and crack-like voids that could serve as strength-limiting flaws.
The measured flexural strength of the ten scaffolds composed of orthogonal long
and short filaments in the x and y directions validated the trends predicted by the FEM
analysis. Using the uniform grid-like (L1S1) microstructure as a reference, redistributing
some of the long rods from middle layers to the top and bottom layers resulted in an
increase in the flexural strength. In comparison, redistributing some of the short rods
from the middle layers to the top and bottom layers resulted in a decrease in flexural
strength (Fig. 7, 9). Scaffolds created with the gradient L3S1 and L4S1 microstructures,
composed of a larger number of long filaments in the top and bottom layers, showed
flexural strengths that were 50% and 130% higher, respectively, than scaffolds with
the L1S1 microstructure.
The measured flexural strength of the S45 scaffolds deviated from the trend for
the LiSi scaffolds. While the FEM simulations predicted a considerably higher tensile
stress in the S45 model (when compared to the L1S1 model), the measured flexural
strength was not different from the L1S1 scaffolds. Unlike the LiSi microstructures that
were composed of long filaments (~23 mm) and short filaments (~4.7 mm), the S45
microstructure was composed of filaments of length ≤ 6.6 mm in all the layers.
Presumably, the probability of a strength-limiting flaw due to processing and
environmental factors was lower in the shorter filaments of the S45 microstructure than
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in the long filaments of the LiSi microstructures. Although a higher tensile stress was
predicted by the FEM simulations, a lower probability of a strength-limiting flaw being
present in the filaments of the S45 microstructure could lead to a measured flexural
strength that was similar to the L1S1 microstructure. However, comparing the L3S1 or
L4S1 microstructure to the S45 microstructure, the structural difference still dominated
over possible effects due to flaws, resulting in a significant increase in flexural strength
which matched the trend predicted by the FEM analysis.
Our previous studies showed that silicate 13-93 bioactive glass scaffolds with the
uniform grid-like (L1S1) microstructure can support bone infiltration and integration with
host bone in vivo [21,22]. Consequently, the gradient L4S1 microstructure was designed
to have a more porous inner region similar to the L1S1 microstructure to support bone
infiltration whereas the top and bottom regions were composed of lower porosity regions
to enhance the flexural strength. The gradient L4S1 microstructure mimics human long
bones that typically consist of an inner region of trabecular bone (porosity = 5090%)
and an outer region of cortical bone (porosity = 510%).
The Weibull modulus, determined from the strength data for a large number of
identical samples (typically 2030 or more) is commonly used as a measure of the
mechanical reliability or the probability of failure of brittle materials [24]. A higher
Weibull modulus is indicative of lower variability in strength, which means that any
microstructural flaws present in the material are more uniform in size and more
uniformly distributed in the material. The Weibull modulus determined in the present
study from the flexural strength of 30 specimens, m = 9 and m = 8, respectively, for the
L3S1 and L4S1 microstructures, were higher than the value ( m = 6) obtained previously
for the scaffolds with the uniform grid-like L1S1 microstructure [13]. The higher Weibull
modulus found in the present study indicates a narrower distribution of flaw sizes in the
glass filaments and therefore a more reliable scaffold. Data for the Weibull modulus of
biomaterials tested in bending are limited. In one study, isotropic glass-ceramic scaffolds
(porosity = 5075%) prepared from a CaOAl2O3P2O5 glass were found to have a
Weibull modulus in the range 38 in four-point bending tests [25].
SEM images of fractured surfaces of the scaffolds with the L3S1 and L4S1
microstructures after testing in four-point bending showed features such as hackle regions,
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mist regions, smooth mirror regions, and arrest lines which are commonly found on the
fractured surface of brittle materials. These features provided useful information for
determining the direction of crack propagation. The SEM images confirmed that failure
of the scaffolds in four-point bending occurred in the direction from the bottom
(subjected to a tensile stress) to the top (subjected to a compressive stress). While the
failure origin of each glass filament could be located, the exact glass filament at which
failure was initiated could not be determined from the SEM images.
4.3 Compressive strength and capacity to support bone infiltration
The FEM simulations showed that redistribution of the filaments in the z direction
from the interior of the uniform grid-like structure (L1S1) to the surface layer (to form
the L3S1 structure) did not lead to a higher tensile stress in the filaments whereas
increasing the number of the filaments in the z direction (L4S1 structure) produced a
reduction in the tensile stress. In general, the measured compressive strength of the
scaffolds validated the predictions of the FEM simulations. The scaffolds with the L3S1
microstructure showed an average compressive strength that was approximately equal to
that for the L1S1 microstructure whereas the average compressive strength of the L4S1
group was 22% higher. This trend is compatible with the color scheme and stress scale
of the FEM predictions in Fig. 12. In combination, the FEM simulations and
experimental data in flexure and compression showed that a redistribution of the glass
filaments in the uniform grid-like structure to form structures with a porosity gradient
resulted in a significant improvement in the flexural strength without a reduction in the
high compressive strength. The FEM simulations provided an efficient approach to
determine the manner in which the filaments should be redistributed.
As the scaffolds in the present study are intended for eventual application in
structural bone repair, the capacity of the scaffolds to support bone infiltration and
integration in vivo is an important factor. Modification of the uniform grid-like (L1S1)
microstructure to form microstructures with a porosity gradient (L3S1 and L4S1) did not
affect the infiltration of bone into the pore space of the scaffolds and the capacity of the
scaffolds to integrate with bone. The percentage of new bone that infiltrated the scaffolds
at 12 weeks, as a percentage of the pore area (volume) of the scaffolds, was independent
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of the scaffold microstructure (Fig. 15). When evaluated as a percentage of the total
defect area, the average amount of new bone that infiltrated the scaffolds with the L4S1
microstructure (9  5%) was lower than the scaffolds with the L1S1 and L3S1
microstructures (15  3% and 19  5%) but the difference was not significant. One factor
that might have contributed to the lower amount of new bone in the L4S1 group was their
lower porosity (33% vs. 43% for the L1S1 and L3S1 groups), providing less pore space
for bone infiltration.
Scaffolds of bioactive 13-93 glass with a uniform grid-like (L1S1) microstructure
have shown the capacity to repair critical size segmental defects in rat femurs [16]. With
their higher flexural strength, coupled with their comparable or higher compressive
strength and their comparable ability to support bone infiltration, scaffolds with a
gradient porosity (L3S1 and L4S1 structures) created in this study could provide more
reliable implants for structural bone repair.
5. Conclusions
Finite element modeling (FEM) was used to simulate the flexural mechanical
response of a variety of porous beam-shaped models composed of ideal glass filaments
bonded orthogonally in adjacent layers to form a grid-like microstructure. The FEM
simulations showed that when compared to a uniform grid-like model, redistribution of
the long filaments from the middle layers to the bottom and top layers resulted in a
decrease in the tensile stress in the bottom layers. In comparison, redistribution of the
short filaments from the middle layers to the bottom and top layers enhanced the tensile
stress of the bottom layers. The measured flexural strength of scaffolds fabricated with
microstructures similar to those in the models validated the predictions of the FEM
simulations. Scaffolds with a porosity gradient, composed of a higher porosity inner
region and a lower porosity outer region to better mimic human long bones, showed a
flexural strength that was more than twice the value of the uniform grid-like
microstructure, coupled with a higher average compressive strength and a comparable
capacity to support bone infiltration in vivo. These scaffolds could provide more reliable
implants for structural bone repair.
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Fig. 1. The external shape and dimensions of the models used in FEM simulations of the
flexural mechanical response. Each filament had a diameter of 330 µm and the thickness
of the partially overlapped region between the filaments in adjacent layers was 90 µm.

Fig. 2. The external shape and structure of the models used in FEM simulations of the
mechanical response in compression. The properties of the filaments were identical to
those used for the simulations in flexure. The center-to-center distance (in µm) between
adjacent filaments in each layer of one-half of each structure is shown below each model.
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Fig. 3. (a) Three-dimensional and (b) planar view of the four-point loading system used
in the FEM simulations. The inner and outer spans were 10 mm and 20 mm, respectively,
and the load was applied in a vertical direction (red arrow).

Fig. 4. Shape and microstructure of scaffolds used for implantation in rat calvarial defects
in vivo. The scaffolds, corresponding to the L1S1, L3S1 and L4S1 models in the FEM
simulations, were 4.6 mm in diameter and 1.5 mm thick and were composed of 7
orthogonal layers of glass filaments. The center-to-center distance (in µm) between
adjacent filaments in each layer of the scaffolds is shown on the right.
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Fig. 5. Typical deformation of the uniform grid-like (L1S1) model in flexure showing the
magnitude and distribution of the stress in the filaments as determined by FEM
simulations. The actual deformation of the model has been magnified by a scale factor of
30. The scale on the left gives the maximum principal stress corresponding to specific
colors.

Fig. 6. The magnitude and distribution of the tensile stress in the long filaments of the
bottom layers of different models when subjected to the same applied load in four-point
bending. The scale on the left gives the maximum principal stress corresponding to
specific colors.
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Fig. 7. Highest tensile stress in the long filaments in the bottom layer of the models
(normalized to the L1S1 model) determined from FEM simulations of four-point bending
under an applied load of 100 N. The region of highest stress corresponded to the middle
region of the bottom filaments between the inner span.

Fig. 8. SEM images of the cross section perpendicular to the long filaments of asfabricated 13-93 bioactive glass scaffolds with three different microstructures. Scale bar
= 500 µm.

79

Fig. 9. (a) Measured load at failure and (b) flexural strength of as-fabricated 13-93
bioactive glass scaffolds with the microstructures shown, tested in four-point bending.

Fig. 10. Weibull plots of the flexural strength data for 13-93 bioactive glass scaffolds
with the L3S1 architecture (a) and L4S1 architecture (b). The straight line shows a leastsquares fit to the data.

80

Fig. 11. SEM images of the fractured surfaces of the scaffolds with the L3S1 architecture
(a-c) and L4S1 architecture (d-f) after testing in four-point bending. The plane (a, d) is
approximately perpendicular to the direction of the long filaments. Higher magnification
images of selected areas in (a), (d) are shown in (b, c) and (e, f). (Top: the side contacting
inner span during the bending test; Bottom: the side contacting outer span; Stars: mirror
region; M: mist region; H: hackle region; A: arrest line; arrow: crack origin; arrowheads:
cantilever curls.)
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Fig. 12. Magnitude and distribution of the tensile stress in the filaments (parallel to xy
plane) of different models when subjected to the same applied load in compression. The
scale on the left gives the maximum principal stress corresponding to specific colors.

Fig. 13. Measured compressive strength of as-fabricated 13-93 bioactive glass scaffolds
with the microstructures corresponding to L1S1, L3S1 and L4S1.
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Fig. 14. Transmitted light images of H&E-stained sections (a1,b1,c1) and von Kossastained sections (a2,b2,c2) of rat calvarial defects implanted for 12 weeks with the three
groups of bioactive glass scaffolds with microstructures corresponding to L1S1, L3S1
and L4S1.

Fig. 15. Amount of new bone area determined as a percentage of the total defect area and
the available pore are, and the total von Kossa positive area determined as a percentage of
the total defect area, for rat calvarial defects implanted for 12 weeks with the three groups
of scaffolds with microstructures corresponding to L1S1, L3S1 and L4S1.
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Table I. Summary of models analyzed in FEM simulations of the mechanical response in
flexure. The models, with the shape of beams, were composed of alternating layers of
long glass filaments (L) and short glass filaments (S) arranged orthogonally along the x
and y axes. The designations LiSi are used to describe the different distribution of the
filaments in the models. Each model was composed of 6 layers of long filaments and 7
layers of short filaments. All the models were composed of the same number of long
filaments (48) and short filaments (259), except for the L4S1 model (66 long filaments
and 259 short filaments). The cross section of the long filaments in the models is also
shown. In addition, a model (S45o) with same porosity as L1S1, but with filaments at 45 o
to the x and y axes was also analyzed. The S45 model was composed of layers with
different porosity as shown.
Long filaments

Short filaments

Model
designation
L1S1
L1S2
L1S3
L2S1
L2S2
L2S3
L3S1
L3S2
L3S3
L4S1

S45

84
Table II. Geometrical parameters of the LiSi models (Table 1) analyzed in FEM
simulations of the mechanical response in flexure. The center-to-center distance (m)
between adjacent glass filaments in the each layer of the models is shown. In the S45 o
model, the center-to-center distance was 581 m and 1054 m, respectively, for the
denser layers and more porous layers.
Long filaments

Short filaments

Layer

L1

L2

L3

L4

Layer

S1

S2

S3

1

630

490

401

367.5

1

630

504

420

2

630

630

630

401

2

630

504

420

3

630

882

1470

630

3

630

945

1890

4

630

882

1470

630

4

630

945

1890

5

630

630

630

401

5

630

945

1890

6

630

490

401

367.5

6

630

504

420

7

630

504

420
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ABSTRACT
Bioactive glass scaffolds have been used to heal small contained bone defects but
their application to repairing structural bone is limited by concerns about their
mechanical reliability. In the present study, the addition of an adherent polymer layer to
the external surface of strong porous bioactive glass (13-93) scaffolds was investigated to
improve their toughness. Finite element modeling (FEM) of the flexural mechanical
response of beams composed of a porous glass and an adherent polymer layer predicted a
reduction in the tensile stress in the glass with increasing thickness and elastic modulus of
the polymer layer. Mechanical testing of composites with structures similar to the models,
formed from 13-93 glass and polylactic acid (PLA), showed trends predicted by the FEM
simulations but the observed effects were considerably more dramatic. A PLA layer of
thickness equal 12.5% of the scaffold thickness increased the load-bearing capacity of
the scaffold by ~50%. The work of fracture increased dramatically, resulting in a change
in mechanical response from brittle to “ductile”. These bioactive glassPLA composites,
combining bioactivity, high strength, high work of fracture and an internal architecture
shown to be conducive to bone infiltration, could provide optimal implants for healing
structural bone defects.
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1. Introduction
Bone defects are a common occurrence in orthopedic surgery, resulting from
trauma, malignancy, infection and congenital disease. Clinically, these defects are
reconstructed through the use of various bone grafts. Whereas small contained bone
defects are repairable with a wide variety of commercially-available osteoconductive and
osteoinductive filler materials [1, 2], the repair of large (critical size) defects in structural
bone is challenging. The available treatments such as bone allografts, autografts and
porous metals are limited by costs, availability, durability, infection risk, donor site
morbidity and uncertain healing. Consequently, there is a clinical need for synthetic
biocompatible materials that can replicate the strength, bioactivity, morphology, porosity
and load-bearing ability of living bone.
Bioactive glasses have been studied and developed as one such material because
they are biocompatible, osteoconductive, convert to hydroxyapatite in vivo, heal readily
to host bone and soft tissues and they are amenable to fabrication into porous threedimensional architectures [3−7]. However, most bioactive glass scaffolds created by
conventional methods have shown low strength, typically compressive strength in a range
comparable to human trabecular bone (212 MPa) [5]. This low strength and a brittle
mechanical response typical of glass have limited the application of bioactive glass
scaffolds to the healing of contained or non-loaded bone defects.
Recent studies using additive manufacturing (rapid prototyping or threedimensional printing) methods have shown the ability to create bioactive glass scaffolds
with a porous grid-like microstructure which have vastly improved compressive strength,
comparable to the strength of human cortical bone (100150 MPa) [8−11]. Despite a
low flexural strength (1015 MPa), much smaller than that of cortical bone (100150
MPa) [9], these strong porous scaffolds have shown the ability to repair critical size
segmental defects in a rat or rabbit femoral model [12, 13]. Modification of the grid-like
microstructure to produce a porosity gradient in in the scaffolds produced a significant
improvement in the flexural strength (35 MPa) without sacrificing their ability to
support bone infiltration [14]. As bending is an important loading in structural bone, this
improvement in flexural strength should improve the mechanical reliability of bioactive
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glass scaffolds in vivo. However, these scaffolds with high compressive and flexural
strength still showed a brittle mechanical response.
Several studies have shown the ability to modify or improve the mechanical
response of porous ceramics or glass by infiltrating the pore volume or coating the pore
surface with a polymer such as a biodegradable polymer composed of polycaprolactone
(PCL) or polylactic acid (PLA) [15–21]. The polymer phase presumably acts as a sealant
to bond together the walls of pre-existing flaws in the surface of the brittle material and
limit the initiation or growth of cracks, providing a defect healing mechanism [15 –17].
Polymers with high elastic modulus, such as PLA, can also assist in partially supporting
the applied load, thereby reducing the effective load on the ceramic or glass phase [15 –
17].
While complete infiltration of the pore space of biocompatible ceramics or glass
scaffolds with a biodegradable polymer can improve their mechanical response, the
absence of porosity could, at least initially, limit bone infiltration and integration of the
scaffolds in vivo. An alternative approach, particularly bioactive materials, is judicious
coating of the pore surface of the scaffolds to provide an optimal combination of
improved mechanical response, bioactivity and porosity conducible to bone or tissue
infiltration. Coating the pore surface of weak bioactive glass (45S5) scaffolds with
poly(D, L-lactic acid) has been found to produce a small improvement in their
compressive and flexural strength but remarkable improvement in their work of fracture
[20]. When encapsulated in a sheath of PLA (500 m), the average flexural strength of
bioactive glass (13-93) scaffolds (external diameter 4.2 mm; porosity20%) formed from
thermally-bonded fibers (300700 m) increased by approximately 2.5 times, from 50
MPa to 120 MPa [21]. Furthermore, the PLA sheath produced a drastic modification of
the brittle mechanical response of the glass scaffolds, resulting in a considerable
improvement in the work of fracture and a “ductile” response.
Based on our previous studies which showed the ability to create strong porous
bioactive glass (13-93) scaffolds with a grid-like microstructure conducive to supporting
bone infiltration [14], the present study was undertaken to modify their brittle mechanical
response and improve their toughness. Finite element modeling (FEM) was used to
simulate the mechanical response in flexural loading of model composites composed of a
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porous glass beam with a grid-like structure and adherent surface layers composed of an
elastic polymer. Then composites with microstructures mimicking the model structures
were created from 13-93 bioactive glass and PLA, and tested in four-point bending to
evaluate their mechanical response.
2. Materials and methods
2.1 Design of composite structures
Three different glass structures, with the external geometry of a beam (23.0 mm
long  4.7 mm wide  3.2 mm thick) and composed of orthogonal glass filaments
(diameter = 330 m) in adjacent layers, were analyzed in FEM simulations (Fig. 1). The
structures were composed of 6 layers of filaments in the long direction of the beam and 7
layers of filaments in the orthogonal direction. These structures were selected on the basis
of a previous study [14]. The structure designated L1S1 was composed of a uniform gridlike arrangement of the filaments in the adjacent layers. In comparison, the structure
designated L3S1 was derived from the L1S1 structure by redistributing some of the long
(L) filaments in the structure from the interior to the top layer and bottom layer but
keeping the number of filaments the same. The L4S1 structure was obtained from the
L3S1 structure by adding additional long filaments to the second layer from the top and
bottom, making these layers identical to the top and bottom laye. All three structures had
the same arrangement of the short (S) filaments. The redistribution of the long filaments
resulted in a porosity gradient in the L3S1 and L4S1 structures, with the top and bottom
layers of the structure having a lower porosity than the interior. FEM simulations and
four-point bending experiments previously showed that the flexural strength of scaffolds
with the L3S1 and L4S1 structures (22  3 MPa and 34  5 MPa, respectively) was
significantly greater than the L1S1 scaffold (15  5 MPa) [14].
Composite structures were designed by adding adherent layers of polymer to the
top and bottom surfaces of the beams (Fig. 2). Layers of thickness 200, 400 and 800 m
were used. Based on observations from experiments described later, a small amount of
polymer infiltration into the surface layer of the glass structure was assumed. Twelve
different structures were analyzed in the FEM simulations, based on the structure of the
glass scaffold and the thickness of the polymer layer (Table I).
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2.2 Finite element simulations
Finite element simulations were carried out using ABAQUS/CAE 6.14-1 software
(Dassault Sytemes Simulia Corp., Providence, RI). Twelve models shown in Table I were
analyzed in four-point bending. The filaments in all the models were assumed to be
composed of a dense homogeneous material with a Young’s modulus of 70 GPa and a
Possion’s ratio of 0.25, values which are comparable to those of a silicate glass [22]. The
polymer layer in the models were assumed to be dense and homogeneous with a Young’s
modulus of 0.65 GPa (measured for the PLA sheets used in this study) and a Poisson’s
ratio of 0.36 (given in the manufacturer’s specifications for PLA). The polymer layer
was assumed to have an elastic response and to be perfectly bonded to the glass surface,
without any delamination under flexural loading.
For the simulations in flexural loading, 4 rigid cylinders with a diameter of 2.0
mm were generated to simulate the fixture used in the four-point bending test, as
described previously [14]. The two upper cylinders, each 5 mm from the midline, served
as the inner span, while the two lower cylinders, 10 mm from the midline, served as the
outer span. The cylinders were in contact with the model composites from the beginning
of the simulations, and the contact was assumed to be hard (no interpenetration between
the materials) and frictionless.
The FEM models were partitioned into several parts in order to improve the
meshing and apply the proper boundary conditions. The FEM models were discretized
with an approximate mesh size of 120 µm and quadratic tetrahedral elements were used.
This size was selected based on a previous study [14] as it provided a good balance
between computing time and convergence to reliable results. The middle of the cross
section perpendicular to x axis was fixed at the x axis direction (U1 = 0) to prevent the
scaffold from sliding in the x axis direction. In addition, the middle of the cross section
perpendicular to y axis was fixed at the y axis direction (U2 = 0) to prevent sliding in the
y axis direction during bending. The two lower cylinders of the fixture were fixed in all
directions (U1 = U2 = U3 = 0) and an evenly distributed load of 100 N was applied to the
two upper cylinders.
A desktop computer with 16 CPU cores and 128 GB of RAM were used for the
simulations. A typical CPU time to complete a simulation was ~4h. As a brittle material,
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glass can withstand much higher stresses in compression than in tension. Consequently,
the highest tensile stress within the inner span of the model was used as the primary
parameter in the load carrying capacity analysis.
2.3 Creation of bioactive glassPLA composites
Bioactive glass (13-93) scaffolds with the geometry of a beam and microstructure
corresponding to the L1S1, L3S1 and L4S1 structure in the FEM simulations were
fabricated using a robotic deposition technique as described in detail elsewhere [14].
Briefly, as-received 13–93 glass frit (Mo-Sci Corp., Rolla, MO) was ground to form
particles (~1 μm), mixed with a 20 wt. % Pluronic-127 binder solution to form a paste
(40 vol. % glass particles) and extruded using a robocasting machine (RoboCAD 3.0; 3-D
Inks, Stillwater, OK). After drying at room temperature, the scaffolds were heated in O 2
at a rate of 0.5 °C min−1 to 600 °C to burn out the processing additives and sintered for 1
h at 700 °C (heating rate = 5 °C min−1) to densify the glass filaments. The external
dimensions of the as-fabricated bioactive glass beams were 23.0 mm long  4.7 mm wide
 3.2 mm thick.
PLA sheets were prepared by dissolving as-received pellets (molecularl weight =
150 kDa; IngeoTM biopolymer 4043D; NatureWorks LLC, Minnetonka, MN) in CHCl 3,
casting the solution on a flat surface and evaporating the solvent slowly. Sheets of
thickness 200, 400 and 800 µm were formed from solutions with different PLA
concentration. The amorphous or crystalline nature of the PLA sheets was checked using
X-ray diffraction XRD (D/mas 2550 v; Rigaku; The Woodlands, TX, USA). Dog-bone
shaped specimens were cut from the sheets (800 µm thick) using a standard fixture and
tested in tension at deformation rates of 210 mm min1 to measure their Young’s
modulus.
A controlled and reproducible procedure was used to bond a PLA layer to the top
and bottom surface of the bioactive glass beams. One surface of a sheet was wetted with
CHCl3 and applied to one surface of the scaffold (in the x-y plane). Then a pressure of
20 kPa was applied to keep the sheet in contact with the scaffold surface and the system
was allowed to dry for 24 hours. The same process was repeated to bond a PLA layer to
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the opposite surface of the bioactive glass scaffold. Excess PLA was trimmed off the
edges of the scaffold.
2.4 Measurement of bioactive glassPLA adhesive strength
The adhesive strength between the PLA layer and the surface of the bioactive
glass scaffold was measured using an adhesion testing apparatus (Romulus universal test
equipment; Quad Group Inc., Spokane, WA). PLA sheets of thickness 800 m were cut
into disks (diameter = 2.6 mm) and bonded to one surface of the bioactive glass scaffold
using the same process described earlier for the preparation of the composite scaffolds.
Then an aluminum rod (2.6 mm in diameter) was bonded to the PLA disk using an
adhesive capable of withstanding a stress >100 MPa. The system was held in the testing
apparatus and the aluminum rod was pulled at a rate of ~2 mm min 1 until delamination
of the PLA layer failed. The adhesive strength was determined from the maximum
recorded load, the total interfacial area between the scaffold and the PLA disc and the
actual area of the PLA disk in contact with the glass scaffold. As the scaffold had a
porous grid-like microstructure, the area of the PLA disc in actual contact with the glass
was lower than the total interfacial area.
2.5 Mechanical testing in four-point bending
Flexural testing of the scaffolds in four-point bending was performed using a fully
articulated fixture (outer span = 20 mm; inner span = 10 mm) at a crosshead speed of 0.2
mm min1 using a 2 kN load cell. The stress was applied in the z direction (the same
direction used in the FEM simulations). Eight samples of each group were tested
according to the procedure described in ASTM C1674-11 and the load versus
deformation curves were recorded. After testing, the samples were examined in a
scanning electron microscope, SEM (S-4700; Hitachi, Tokyo, Japan) and by optical
microscopy (KH-8700; Hirox-USA, Inc., Hackensack, NJ).
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2.6 Statistical analysis
The data are presented as a mean ± standard deviation (SD). Analysis for
differences between groups was performed using one-way analysis of variance (ANOVA)
with Tukey’s post hoc test. Differences were considered significant for p < 0.05.
3. Results
3.1 Finite element simulations
The deformation of a model composite composed of a glass scaffold with the
L1S1 structure and an adherent polymer surface layer of thickness 200 µm in four-point
bending is shown in Fig. 3. The deformation of the composite beam was magnified 15
times (scale factor = 15) for ease of observation. Similar deformation profiles were found
for the other composites that were analyzed. The distribution of the maximum principal
stress (S, Max. Principal (Abs.)) in the deformed structure is also shown in color, as
represented by the scale in Fig. 3. Negative tensile stress was found in the top layers of
the scaffold as they were in compression during the bending. The highest tensile stress
was present in the long filaments of the bottom layer in the y-direction. As the polymer
layer could deform more easily than the glass filaments due to its much lower Young’s
modulus, the tension was much lower in the PLA layer. According to the maximum
principal stress theory (Tresca), failure will occur when the maximum principal stress in a
system reaches the maximum stress at the elastic limit in simple tension. This is
approximately valid for brittle materials such as glass. Consequently, particular attention
was paid to differences in the magnitude and distribution of the stress in the bottom
layers of the glass filaments of the various models.
The magnitude and distribution of the tensile stress in the long filaments at the
middle of the bottom layers of the models are shown in Fig. 4. The highest tensile stress
was present at the contact region between the long and short filaments. Fig. 5 shows the
magnitude of the highest tensile stress for the various models. For models with same
polymer layer thickness, the highest tensile stress was in the order L1S1 > L3S1 > L4S1,
which is in consistent with the results of previous simulations for the same glass
structures without a polymer layer [14]. For models with same glass structure but
different polymer layer thickness, the simulations predicted a small decrease in the
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magnitude of the tensile stress (or the area with same magnitude of the tensile stress) in
the glass filaments with increasing thickness of the PLA coating. For a PLA layer
thickness of 800 m, the highest stress in the filaments decreased by less than 10% when
compared to the scaffold without a PLA layer.
The effect of the Young’s modulus of the polymer layer was also analyzed. For a
model composed of a glass scaffold with the L1S1 structure and a polymer layer of
thickness 200 µm, Fig. 6 shows the magnitude and distribution of the tensile stress in the
glass filaments near the middle of the bottom layers. The tensile stress decreased with
increasing Young’s modulus of the polymer layer.
3.2 Mechanical response of as-fabricated bioactive glass PLA composites
X-ray diffraction patterns of the PLA sheets used in this study showed strong
well-defined peaks corresponding to crystalline PLA and broad low-intensity bumps
indicative of an amorphous PLA phase (results not shown). The results indicate that the
PLA layers in the composites were semi-crystalline and not amorphous (results not
shown). The measured stress vs. strain curves and the Young’s modulus determined from
the initial linear region of the curves at cross-head speeds of 2, 5 and 10 mm/min are
shown in Fig. 7. As generally observed for polymeric materials, the Young’s modulus
increased with increasing strain rate. The PLA sheet showed an elastic response at strains
less than 12% for the strain rates used, which was considerably larger than the strain to
failure of the bioactive glass (0.1%).
Optical images of as-fabricated bioactive glassPLA composites with a PLA layer
thickness of 200, 400 and 800 µm are shown in Fig. 8. The PLA layers appeared to have
a uniform thickness and they partially infiltrated the macroporous surface of the glass
scaffolds (the space between the short glass filaments at the surface). Higher
magnification examination in the SEM revealed the presence of a few isolated pores
within PLA layer. These pores existed though the entire thickness of the 200 m PLA
layer which meant that the glass surface immediately below these through-thickness
pores was bare. Apparently, the 200 m PLA layer was not sufficiently thick to provide a
complete uniform layer over the entire surface of the glass scaffold. No through-thickness
pores were observed in the 400 m or 800 m PLA layer. The measured adhesive
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strength between the PLA layer and the glass scaffold was 1.0 ± 0.1 MPa based on the
total interfacial area. Because of the porous nature of the scaffold surface, the actual
contact area between the PLA and the glass was estimated to be approximately two-thirds
of the total interfacial area. If the actual contact area was used, the adhesive strength was
1.5 MPa.
After the adhesion test, the surface of the PLA which was previously adherent on
the glass scaffold showed a structure composed of bumps and valleys that replicated the
macroscopic structure of the glass scaffold surface. This indicated some degree of
mechanical interlocking between the PLA and the glass scaffold (Fig. 9a). The glass
scaffold showed the presence of residual adherent PLA which but this was situated
mainly at the junctions between the two outermost layers of glass filaments (Fig. 9b). The
“smooth” surface of the glass filaments previously in contact with the PLA layer showed
little residual PLA.
Typical load versus strain curves in four-point bending for composites formed
from 13-93 bioactive glass scaffolds with the L1S1 structure and different PLA layer
thickness are shown in Fig. 10a. The glass scaffold without a PLA layer showed a typical
brittle mechanical response (rapid failure after an elastic response). The applied load
showed a peak followed by a rapid decrease as the structure fractured and was unable to
support the load. For a PLA layer thickness of 200 µm, the peak load increased by 50%
but a brittle mechanical response was still observed. In comparison, the composites with
a PLA layer thickness of 400 or 800 µm showed a dramatic change in mechanical
response. First, the peak load increased, showing the ability of the composite to support a
higher load than the glass scaffold alone (without a PLA layer). When compared to the
glass scaffold alone, the peak load increased by ~95% and ~110%, respectively, for
composites with PLA layer thicknesses of 400 and 800 m. Second, the composite did
not fail in a brittle manner. Instead, the composite was able to support a considerable load
at strains up to as high as 2.5% when the experiments were terminated. The load versus
strain curves showed additional peaks and valleys, and the load supported by the
composite when the experiments were terminated was even higher than the load at the
first peak. The area under the load versus strain curve, referred to as the work of fracture
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(which is a measure of the toughness), showed a very large increase over the bioactive
glass scaffold alone or the composite with a 200 m PLA layer.
The mechanical response of composites formed from a bioactive glass scaffold
with a gradient in porosity (L3S1 or L4S1 structure) and PLA layer thickness of 400 or
800 µm showed trends similar to the composite with the L1S1 glass structure and PLA
layers of the same thickness (Fig. 10b). The measured load at the first peak in the load
versus strain curve (referred to as the load-bearing capacity) is summarized in Fig. 11 for
all the composites. For a PLA layer thickness of 400 m, the load-bearing capacity was
100 N, 84 N, and 72 N, respectively, for scaffolds with the L4S1, L3S1, and L1S1
structure. The load-bearing capacity L4S1 glass scaffold with a 400 m or 800 m PLA
layer increased by 200% when compared to the L1S1 scaffold without a PLA layer.
SEM images of a composite formed from a 13-93 glass scaffold with the L1S1
structure and 200 m PLA layer after testing in four-point bending are shown in Fig. 12a,
b. The crack initiated at the contact region between the long and short filaments, the same
region that showed the highest tensile stress in the FEM simulations. Then the crack
propagated further (upward in the z direction) via a path along similar contact regions
between the long and short filaments. The initiation and propagation of the crack resulted
in a brittle failure mode, similar to the glass scaffold alone, presumably because the
composite was unable to support the applied load.
Examination of composites formed from a bioactive glass scaffold (L1S1, L3S1
or L4S1 structure) and PLA layers of thickness 400 or 800 m after testing to different
points of the load vs. strain curve showed the presence of more than one crack in most
specimens (Figure 12c, d, e). In general, the occurrence of these cracks was correlated
with successive peaks in the load versus strain curve. The first crack was correlated with
the first peak and additional cracks were correlated with subsequent peaks. Thus the
composite did not fail catastrophically due to the propagation of a single crack. Instead,
smaller cracks formed periodically in different parts of the glass scaffold which allowed
the composite to maintain its overall integrity as a whole and to continue to support a
considerable load.
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4. Discussion
The results of the present study showed the ability to significantly improve the
load-bearing capacity and to dramatically enhance the work of fracture of strong porous
bioactive glass scaffolds in four point bending. This was achieved by the addition of an
adherent polymer layer to the external surface of the scaffolds. Finite element simulations
of model composites predicted an improvement in the load-bearing capacity of the glass
scaffold in four-point bending with increasing thickness and elastic modulus of the
polymer layer. Mechanical testing of 13-93 bioactive glassPLA composites created with
structures similar to the models showed effects that were considerably larger and more
dramatic than those predicted by the simulations. The load-bearing capacity of the
bioactive glass scaffold increased significantly with the addition of the PLA layer. For a
sufficiently thick PLA layer (greater than 12.5% of the scaffold thickness), the work of
fracture increased dramatically, resulting in a non-brittle (or “ductile”) mechanical
response. These composites, combining bioactivity, high strength, high work of fracture
and an internal architecture previously shown to be conducive to bone infiltration, could
provide optimal synthetic implants for healing structural bone defects.
4.1 FEM simulations
The FEM analysis focused on simulating the flexural mechanical response of
model composite structures composed of a porous glass beam and an adherent polymer
surface layer on the top and bottom surface of the beam. The beam geometry was used
because it is relevant to flexural testing in four-point bending. The glass had a grid-like
structure composed of layers of long (L) filaments along the length of the beam and short
(S) filaments in adjacent layers in the orthogonal direction. According to the maximum
principal stress theory, failure will occur when the maximum principal stress in a system
reaches the value of the maximum stress at the elastic limit in simple tension.
Consequently, the analysis focused on determining the magnitude and distribution of the
tensile stress in the structure when subjected to a constant load in four-point bending.
For glass structures with a uniform grid-like structure (L1S1) (without a polymer
surface layer) the simulations showed that the highest tensile stress was present in the
long filaments at the bottom surface of the beam (Fig. 3), in accordance with a previous
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study [15]. The addition of an adherent polymer layer to the top and bottom surface of the
beam resulted in a reduction in the tensile stress in the glass filaments. The magnitude of
the tensile stress in the bottom filaments of the glass scaffold decreased with increasing
thickness and elastic modulus of the polymer layer (Fig. 4, 5, 6). However, the reduction
predicted by the simulation was <10% for the thickest PLA layer (800 µm) used in the
simulations.
As the polymer layer was assumed to be elastic and perfectly bonded to the glass
surface, the reduction in the tensile stress of the glass structure was apparently due to
stress transfer to the polymer layer and the capacity of the polymer layer to share a
fraction of the applied load. The reduction in the tensile stress of the glass filaments
means that when compared to the glass structure alone (without the polymer layer), the
composite can support a higher load prior to failure of the brittle glass structure. The
composite is predicted to have a higher load-bearing capacity than the glass structure
alone. However, because the elastic modulus of the PLA used in the present study (0.65
GPa) was considerably lower than that of the glass the glass (70 GPa), the fraction of the
load shared by the polymer layer was limited. The simulations showed similar trends for
composites in which the glass structure had a gradient in porosity (L3S1 and L4S1
structures). However, for a given thickness of the polymer layer, the magnitude of the
reduction (when compared to the L1S1 glass scaffold without a polymer layer) was larger
for the L3S1 structure and even larger still for the L4S1 structure (Fig. 5).
4.2 Observed mechanical response of bioactive glass PLA composites
The bioactive glass scaffolds created by robotic deposition had grid-like
microstructures that well approximated the structures used in the FEM simulations. The
glass filaments were almost fully dense and only a few fine pores were found within the
cross section of the filaments which corresponded well to the fully dense glass filaments
assumed in the models. Tensile testing of PLA specimens at deformation rates of 210
mm/min showed an elastic limit of 12% that was considerably larger than the failure
strain (<0.1%) of the bioactive glass scaffolds in four-point bending. Consequently, the
PLA layer can be considered to be elastic in four-point bending of the bioactive
glassPLA composites, as assumed in the FEM models.
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Examination of the as-fabricated composites showed that the PLA layer adhered
to the glass filaments at the surface of the scaffold (Fig. 8). The adhesive strength of the
bioactive glassPLA interface measured in a standard pullout test was 1.01.5 MPa.
After the pullout test, the surface of the PLA previously in contact with the scaffold
showed grooves and bumps that replicated the grid-like structure of the scaffold surface.
Residual PLA adhered to the scaffold but it was situated mainly at the junctions between
the two outermost layers of glass filaments (Fig. 9). In general, these observations
confirmed that the PLA layer adhered to the scaffold but perfect interfacial bonding
assumed in the FEM simulations was apparently not present.
For scaffolds with a uniform grid-like microstructure (L1S1), the peak value in
the load versus strain curve increased with increasing thickness of the PLA layer (Fig.
10a). The addition of an adherent PLA layer of thickness 400 m to the top and bottom
surfaces of the bioactive glass beam (thickness = 3.2 mm) resulted in a 100% increase in
the flexural load that can be supported by the glass beam alone. An increase in the PLA
layer thickness to 800 m produced a further increase in the average peak load but the
increase was not significant when compared to the scaffold with the 400 m PLA layer
(Fig. 11).
In general, the observed mechanical response of the bioactive glassPLA
composites in four-point bending showed trends predicted by the FEM simulations but
the effects were considerably stronger and more dramatic. The addition of a 400 m PLA
layer improved the load-bearing capacity of the bioactive glass scaffold with the L1S1
structure by 100%. In comparison, the tensile stress in the glass filaments in the bottom
layer of the models was predicted to decrease by 3% in the FEM simulations. Similar
trends were observed for bioactive glass scaffolds with a porosity gradient (L3S1 and
L4S1 structures). The difference between the predicted and observed lead-bearing
capacity of the bioactive glassPLA composites was presumably due to the deviations of
the model assumptions from the as-fabricated composites.
In the FEM model, the glass was assumed to be fully dense and devoid of flaws.
In comparison, the mechanical response of brittle materials, particularly when subjected
to a tensile stress, is known to be strongly dependent on the presence of surface flaws and
internal microstructural flaws. In the present study, the bioactive glass filaments in the as-
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fabricated scaffolds were almost fully dense, containing only a few isolated fine pores.
Consequently, the difference between the predictions of the FEM simulations and the
measured mechanical response was presumably due to the presence of surface flaws in
the glass filaments. As the surface of the PLA layer was softened by wetting with CHCl 3
and applied to the surface of the glass scaffold by means of a low applied load, it is likely
that the PLA might have filled surface flaws, in addition to adhering to the glass surface.
This could result in reducing the effect of the surface flaws present in the as-fabricated
glass scaffolds.
A striking feature of the observed mechanical response was that the addition of
the PLA layer did not just improve the load-bearing capacity of the bioactive glass
scaffold. The PLA layer also dramatically modified the type of mechanical response. A
PLA layer thickness of 400 m (~12.5% of the glass scaffold thickness) significantly
enhanced the work of fracture, in addition to significantly enhancing the load-bearing
capacity of the bioactive glass scaffold. Increasing the PLA layer thickness to 800 m
(~25% of the glass scaffold thickness) did not provide significant improvements in the
mechanical response when compared to the 400 m PLA layer. In comparison,
composites with a PLA layer thickness of 200 m showed a brittle mechanical response
typical of the glass scaffold, although there was a significant increase in the failure load
(Fig. 11).
As the same process was used to bond the PLA layers to the surface of the
bioactive glass scaffolds, it is expected that the interfacial characteristics would be
independent of the PLA layer thickness. The difference in mechanical response (brittle
versus “ductile”) between the composite with the 200 m PLA layer and those with the
400 m or 800 m PLA layer was presumably due to the processing method used to
attach the PLA layer to the glass scaffold. As described earlier, the 200 m PLA layer
was apparently not sufficiently thick to provide complete coverage over the entire surface
of the scaffold. A few isolated through-thickness pores were present in the 200 m PLA
layer and the glass under these pores was essentially bare. These bare glass regions,
although few in number and small in size, could nevertheless provide sources of brittle
failure for the composite with the 200 m PLA layer.
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Another interesting feature of the results was the occurrence of multiple peaks and
valleys in the load versus strain curves in four-point bending for composites with a PLA
layer thickness of 400 or 800 m (Fig. 10). These peaks were correlated with the
initiation and propagation of successive cracks in the glass scaffold. Furthermore, at
strains of up to 5% when the experiments were terminated, the load supported by the
composite was comparable or even higher than the load at the first peak. For the glass
scaffolds with a PLA layer thickness of 200 m, a single crack initiated and propagated
rapidly, resulting in failure following a peak load. In comparison, multiple cracks formed
in succession in the glass scaffold with a PLA layer thickness of 400 or 800 m, and the
spacing between the two surfaces of the crack was much smaller than that for the glass
scaffold with the 200 m PLA layer (Fig. 12). Apparently, these multiple cracks with
smaller separation between the crack surfaces enabled the composite to maintain its
integrity and support a considerable load.
4.3 Potential of bioactive glass composites for structural bone repair
Although the tough and strong bioactive glassPLA composites created in the
present study were not evaluated in vivo, the bioactive glass scaffolds by themselves
(without the PLA surface layer) were shown previously to have a microstructure
conducive to bone infiltration in vivo [15]. When implanted in rat calvarial defects for 12
weeks, bioactive glass (13-93) scaffolds with microstructures corresponding to the L1S1,
L3S1 and L4S1 structures were infiltrated with new bone. The amount of new bone that
infiltrated the pore space of the scaffolds (3537%) was not dependent on the
microstructure of the three groups of scaffolds. Furthermore, the amount of new bone
infiltration was higher than that observed for the same glass with a fibrous, trabecular or
oriented microstructure [24]. As the PLA layers are present only on the external surface
of the bioactive glass scaffold, the porous internal architecture can degrade, release ions
that stimulate osteogenesis and support bone infiltration in more or less the same way as
a glass scaffold without the PLA layer. The PLA layer on the external surface of the
scaffold will degrade and eventually disappear.
Scaffolds of 13-93 bioactive glass with a uniform grid-like (L1S1) microstructure
(without a PLA layer), with a compressive strength of 72  10 MPa and flexural strength
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of 15  5 MPa, have already shown the capacity to heal segmental defects in rat femurs
[13]. Scaffolds of 13-93 glass with a similar microstructure have also shown the capacity
to heal segmental defects in rabbit femurs [14]. Bioactive glass (13-93) scaffolds with the
L4S1 structure (without a PLA layer) have a higher compressive strength (88  20 MPa)
and a significantly higher flexural strength of (34  5 MPa) than the scaffolds used in
those studies. With the addition of a 400 m or 800 m PLA layer, the flexural loadbeating capacity of the L4S1 scaffold increased by 33% and ~50%, respectively, and its
mechanical response changed dramatically from brittle to “ductile”. These composites
formed from 13-93 bioactive glass with the L4S1 structure and an adherent PLA surface
layer (400 or 800 m thick) can provide more reliable implants for structural bone repair.
5. Conclusions
The addition of an adherent polylactic acid (PLA) layer to the external surface of
strong porous bioactive glass (13-93) scaffolds with a grid-like microstructure
significantly enhanced their load-bearing capacity and dramatically modified their
mechanical response. Finite element modeling (FEM) predicted an improvement in the
load-bearing capacity of the glass scaffolds with increasing thickness and elastic modulus
of an adherent polymer surface layer. Mechanical testing of 13-93 bioactive glassPLA
composites created with structures similar to the models showed trends predicted by the
FEM simulations but the observed effects were considerably larger and more dramatic. A
PLA layer thickness equal 12.5% of the scaffold thickness increased the load-bearing
capacity of the scaffold by ~50% and enhanced the work of fracture increased
dramatically, resulting in a change in mechanical response from brittle to “ductile”. These
bioactive glassPLA composites, combining bioactivity, high strength, high work of
fracture and an internal architecture known to be conducive to bone infiltration, could
provide optimal implants for healing structural bone defects.
Acknowledgements: Supported by the National Institutes of Health (NIDCR), Grant #
1R15DE023987-01 and Missouri University of Science and Technology.

102
References
[1] P.V. Giannoudis, H. Dinopoulos, E. Tsiridis, Bone substitutes: an update, Injury 36
(2005) S20−7.
[2] C. Laurencin, Y. Khan, S.F. El-Amin, Bone substitutes, Expert. Rev. Med. Devices 3
(2006) 49−57.
[3] L-C. Gerhardt, A.R. Boccaccini, Bioactive glass and glassceramic scaffolds for bone
tissue engineering, Materials 3 (2010) 3867−910.
[4] M.N. Rahaman, D.E. Day, B.S. Bal, Q. Fu, S.B. Jung, L.F. Bonewald, A.P. Tomsia,
Bioactive glass in tissue engineering, Acta Biomater. 7 (2011) 2355−73.
[5] Q. Fu, E. Saiz, M.N. Rahaman, A.P. Tomsia, Bioactive glass scaffolds for bone tissue
engineering: state of the art and future perspectives, Mater. Sci. Eng. C 31 (2011)
1245−56.
[6] J.R. Jones, Review of bioactive glass: From Hench to hybrids, Acta Biomater. 9
(2013) 4457− 86.
[7] S.M. Giannitelli, D. Accoto, M. Trombetta, A. Rainer, Current trends in the design of
scaffolds for computer-aided tissue engineering, Acta Biomater. 10 (2014) 580−94.
[8] A. Deliomanli, M.N. Rahaman, Direct-write assembly of silicate and borate bioactive
glass scaffolds for bone repair, J. Eur. Ceram. Soc. 32 (2012) 3637−46.
[9] X. Liu, M.N. Rahaman, G.E. Hilmas, B.S. Bal, Mechanical properties of bioactive
glass scaffolds fabricated by robotic deposition for structural bone repair, Acta
Biomater. 9 (2013) 7025−34.
[10] N.D. Doiphode, T.S. Huang, M.C. Leu, M.N. Rahaman, D.E. Day, Freeze extrusion
fabrication of 13-93 bioactive glass scaffolds for bone repair, J Mater Sci: Mater Med
22 (2011) 51523.
[11] Q. Fu, E. Saiz, A.P. Tomsia, Bioinspired strong and highly porous glass scaffolds,
Adv. Funct. Mater. 21 (2011) 1058−63.
[12] Q. Fu, E. Saiz, A.P. Tomsia, Direct ink writing of highly porous and strong glass
scaffolds for load-bearing bone defects repair and regeneration, Acta Biomater. 7
(2011) 3547−54.
[13] L. Bi, B. Zobell, X. Liu, M.N. Rahaman, L.F. Bonewald, Healing of critical-size
segmental defects in rat femora using strong porous bioactive glass scaffolds, Mater.
Sci. Eng. C 42 (2014) 816−24.
[14] W. Jia, G.Y. Lau, W. Huang, C. Zhang, A.P. Tomsia, Q. Fu, Bioactive glass for
large bone repair, Adv. Healthc. Mater. 4 (2015) 2842−8.
[15] W. Xiao, M. Asle Zaeem, B.S. Bal, M.N. Rahaman, Creation of bioactive glass (1393) scaffolds for structural bone repair using a combined finite element modeling
and rapid prototyping approach, Mater. Sci. Eng. C 68 (2016) 651−62.

103
[16] F.J. Martinez-Vazquez, F.H. Perera, I. van der Meulen, A. Heise, A. Pajares, P.
Miranda, Impregnation of β-tricalcium phosphate robocast scaffolds by in-situ
polymerization, J. Biomed. Mater. Res. A 101 (2013) 3086–96.
[17] F.J. Martinez-Vazquez, P. Miranda, F. Guiberteau, A. Pajares, Reinforcing
bioceramic scaffolds with in-situ synthesized ε-polycaprolactone coatings, J. Biomed.
Mater. Res. A 101 (2013) 3551–9.
[18] F.J. Martinez-Vazquez, A. Pajares, F. Guiberteau, P. Miranda, Effect of polymer
infiltration on the flexural behavior of β-tricalcium phosphate robocast scaffolds,
Materials 7 (2014) 4001–18.
[19] M. Peroglio, L. Gremillard, J. Chevalier, L. Chazeau, C. Gauthier, T. Hamaide,
Toughening of bio-ceramics scaffolds by polymer coating, J. Eur. Ceram. Soc. 27
(2007) 2679–85.
[20] Q. Fu, E. Saiz, M.N. Rahaman, A.P. Tomsia, Toward strong yet tough glass and
ceramic scaffolds, Adv. Func. Mater. 23 (2013) 246176.
[21] Q.Z. Chen, A.R. Boccaccini, Poly(D,L-lactic acid) coated 45S5 Bioglass®-based
scaffolds: processing and characterization, J. Biomed. Mater. Res. A 3 (2006) 445–
57.
[22] D.E. Day, A. Mohammadkhah, Biodegradable composite scaffold for repairing
defects in load-bearing bones, Patent US20140277578A1, Sep 18, 2014.
[23] A.M. Korsunsky, Encyclopedia of Materials: Science and Technology, Oxford (UK),
Pergamon, 2001, pp. 2398–404.
[24] X. Liu, M.N. Rahaman, Y. Liu, B.S. Bal, L.F. Bonewald, Enhanced bone
regeneration in surface-modified and BMP-loaded bioactive glass (13-93) scaffolds
in a rat calvarial defect model, Acta Biomater. 2013;9:750617.

Fig. 1. Three different structures of the glass scaffold analyzed in finite element
modeling. Each structure had the external geometry of a beam and was composed of 6
layers of long (L) filaments in the y direction and 7 alternating short (S) filaments in the x
direction. The inset under each structure shows the arrangement of the long filaments in
the xz plane.
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Fig. 2. Cross section of composite composed of glass scaffold and adherent polymer
(PLA) surface layer of thickness 200, 400 and 800 m. The polymer layer was assumed
to partially infiltrate the top and bottom surface of the scaffold.

Fig. 3. Typical deformation of glasspolymer composite in four-point bending showing
the magnitude and distribution of the stress in the glass filaments and polymer layer as
determined by FEM simulations. The actual deformation of the model was magnified by
a scale factor of 15 to better show the deformation. The scale on the left gives the
maximum principal stress corresponding to specific colors. The box shows the region of
most interest in the simulations.
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Fig. 4. Magnitude and distribution of the tensile stress in the long filaments of the bottom
layers of different models when subjected to the same applied load in four-point bending.
The scale on the left gives the maximum principal stress corresponding to specific colors
for each row. The designations of the models are given in Table I.

Fig. 5. Highest tensile stress in the long filaments in the bottom layer of the models
(normalized to the L1S1 model) determined from FEM simulations of four-point bending
under an applied load of 100 N. The region of highest stress corresponded to the middle
region of the bottom filaments between the inner span.
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Fig. 6. Magnitude and distribution of the tensile stress in the long filaments of the bottom
layers of different models with polymer surface layers of thickness 200 or 800 m and
elastic modulus of 0.65, 2.1, 3.6 and 5.1 GPa when subjected to the same applied load in
four-point bending. The scale on the left gives the maximum principal stress
corresponding to specific colors.

Fig. 7. Stress vs. strain curves for PLA sheets of thickness 800 m measured in tensile
testing of dog-bone specimens (inset) at different deformation rates shown. The Young’s
modulus is also shown for each deformation rate.
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Fig. 8. Side view of as-fabricated composed of bioactive glass (13-93) scaffolds with a
grid-like (L1S1) structure and adherent PLA surface layer of thickness (a) 200 µm; (b)
400 µm; (c) 800 µm.

Fig. 9. (a) Schematic diagram illustrating the fixture used in the adhesive strength test; (b)
surface of PLA layer (previously in contact with the bioactive glass scaffold) after pullout
test; (c) surface of bioactive glass scaffold after pullout test showing residual PLA
adhering to the glass. The dashed lines in (b) outline grooves in the PLA layer which
replicate the filaments (indicated by solid lines) at the surface of the glass scaffolds in (c).
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Fig. 10. Typical load vs. strain curves for bioactive glass (without PLA) and composites
composed of bioactive glass (13-93) scaffolds with the different scaffold structures with
different thickness of PLA coating.

Fig. 11. Measured load at the first peak of the load vs. strain curves in four-point bending
for different groups of bioactive glass scaffolds (L1S1, L3S1 and L4S1) and composites
of these scaffolds with PLA surface layers of thickness 200, 400 or 800 m. (* significant
difference between groups; p < 0.05).
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Fig. 12. SEM images of bioactive glassPLA composites (yz plane) after testing to
specific strains in four-point bending. (a) Glass scaffold with the L1S1 structure and PLA
layer thickness of 200 µm; a magnified images of the boxed area in (a) is shown in (b).
(c) Glass scaffold with the L4S1 structure and PLA layer thickness of 400 µm; magnified
images of the boxed areas in (c) are shown in (d) and (e).

Table I. Summary of models analyzed in FEM simulations.
Glass scaffold architecture

Polymer (PLA) layer thickness (m)
200

400

800

L1S1

L1S1+200

L1S1+400

L1S1+800

L3S1

L3S1+200

L3S1+400

L3S1+800

L4S1

L4S1+200

L4S1+400

L4S1+800
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SECTION
2. CONCLUSIONS
1. Hollow hydroxyapatite (HA) microspheres with a high-surface-area mesoporous shell
wall, prepared by a borate glass conversion route near room temperature, can provide a
novel carrier for local delivery of bone morphogenetic protein-2 (BMP2) to stimulate
bone regeneration.
2. The release of BMP2 from the hollow HA microspheres can be further controlled,
particularly at early times, by coating the microspheres with a biodegradable polymer of
varying thickness.
3. When loaded with BMP2 (1 µg per defect), the hollow HA microspheres significantly
enhanced bone regeneration in rat calvarial defects at 3−6 weeks postimplantation.
4. Hollow microspheres with controllable amounts of carbonate substitution (0−12 wt. %)
can be prepared by modifying the process variable in the glass conversion route.
5. Hollow HA microspheres with 12.4 wt. % carbonate ions showed a higher surface area
(236 m2 g−1) than hollow HA microspheres prepared without carbonate substitution (179
m2 g−1) and a faster degradation rate in a potassium acetate buffer solution in vitro.
6. When implanted for 12 weeks in rat calvarial defects, the hollow HA microspheres
(with or without carbonate substitution) showed a limited capacity to regenerate bone in
rat calvarial defects but the carbonate-substituted HA microspheres (12.4 wt. % carbonate
ions) resorbed faster than the HA microspheres without carbonate substitution.
7. When loaded with BMP2 (1 µg per defect), the carbonate-substituted hollow HA
microspheres stimulated bone regeneration and resorbed faster than the HA microspheres
without carbonate substitution.
8. The combination of carbonate-substituted hollow HA microspheres and clinically-safe
doses of BMP2 could provide promising implants for healing non-loaded bone defects.
9. Finite element modeling (FEM) provided an efficient approach to simulate the
mechanical response of a variety of glass architectures relevant to the development of
strong porous bioactive glass scaffolds.
10 Mechanical testing of bioactive glass (13-93) scaffolds created with microstructures
approximating the finite element models by a robotic deposition technique showed results
that validated the predictions of the FEM simulations.
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11. Bioactive glass (13-93) scaffolds with a porosity gradient, composed of a higher
porosity inner region and a lower porosity outer region to better mimic human long bones,
showed a flexural strength that was more than twice the value for a uniform grid-like
microstructure, a higher average compressive strength and a comparable capacity to
support bone infiltration in vivo.
12. The addition of an adherent polylactic acid (PLA) layer to the external surface of
strong porous bioactive glass (13-93) scaffolds with a grid-like microstructure
significantly enhanced their load-bearing capacity by ~50% and dramatically modified
their mechanical response.
13. The measured load-bearing capacity of the glass scaffold increased with increasing
PLA layer thickness and, above a certain PLA thickness (<12.5% of the scaffold
thickness), the work of fracture increased dramatically, resulting in a non-brittle (or
“ductile”) mechanical response.
14. The bioactive glassPLA composites created in this study, combining bioactivity,
high strength, high work of fracture and an internal architecture conducive to bone
infiltration, could provide optimal implants for healing structural bone defects.
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3. SUGGESTIONS FOR FUTURE WORK
1. Create and evaluate hollow carbonate-substituted HA microspheres doped with
therapeutic ions
Trace amount of elements such as Cu, Zn and Sr are known to be beneficial for
bone regeneration. Hollow carbonate-substituted HA microspheres doped with these
elements should be studied to evaluate their ability to enhance bone regeneration and
angiogenesis in osseous defects without the use of growth factors.
2. Determine the optimal amount of BMP2 for use with hollow HA microspheres
The amount of BMP2 loading (1 μg/defect) used in this study was based on data
in the literature for the same animal model. It is not clear whether the amount used in this
study is the optimal amount for bone regeneration. BMP2 is expensive and large amounts
of BMP2 can have adverse effects in vivo. Hollow carbonate-substituted HA
microspheres doped with therapeutic ions could potentially reduce the amount of BMP2
required for same amount of new bone. The microspheres loaded with different amounts
of BMP2 should be evaluated in bone defects to determine the optimal BMP2 dose.
3. Improve sophistication of finite element modeling
The simulations performed in this study assumed glass filaments without surface
flaws. In practice, glasses commonly contain surface flaws such as pores and microcracks
that have a strong effect on their mechanical response, particularly when subjected to
tensile stresses. Incorporation of controlled surface flaws of the glass into the finite
element simulations could potentially provide further insight into creating bioactive glass
scaffolds with improved mechanical properties.
4. Evaluation of bioactive glassPLA composites in loaded bone defect model
The present study culminated in the creation of bioactive glass-based scaffolds
with a desirable combination of properties that have sought after for several years:
bioactivity, high compressive strength, high flexural strength, non-brittle mechanical
response and an internal architecture conducive to bone infiltration. The composites
should be evaluated in a loaded bone defect model, such as critical-size segmental defects
in rabbit femurs. Bone regeneration in the defects and the biomechanical properties of the
scaffolds should be studied as a function of implantation time.
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Abstract
Silicon nitride (Si3N4) implants are used in spinal fusion surgery and are under
development for use as bearings in total joint arthroplasty. The ability to create Si 3N4
implants with anatomically relevant shapes and controllable architecture can be beneficial
in these orthopedic applications. In the present study, an aqueous paste composed of
Si3N4 powder and sintering additives was prepared with the requisite rheology and
formed into structures with different geometry and architecture using a robotic deposition
technique. Sintering and hot isostatic pressing produced an almost fully dense Si 3N4
phase (density = 3.23 ± 0.02 g/cm3) with a fibrous microstructure. Four-point bending
tests of as-fabricated dense beams showed a flexural strength of 552 ± 68 MPa. Together,
these results indicate that robotic deposition combined with sintering and hot isostatic
pressing can provide a manufacturing strategy to create Si3N4 implants with controllable
shape and architecture for applications in orthopedic surgery.

Introduction
During the past 50 years, silicon nitride (Si 3N4) has developed into a wellestablished material for several structural applications, at both ambient and high
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temperatures, due to its attractive combination of properties such as mechanical strength,
resistance to thermal shock, high-temperature stability, hardness and wear resistance. 1−3
Si3N4 materials fabricated by conventional powder processing routes can be modified by
controlled thermal treatment to produce a microstructure composed of elongated (fibrous)
grains with enhanced fracture toughness. These in situ toughened Si3N4 ceramics have
shown a combination of flexural strength (>1 GPa) and fracture toughness (up to 10 MPa
m1/2) that are among the highest measured values for ceramic materials. 3,4 Medical grade
Si3N4 has also been shown to be biocompatible, stable in vivo and visible on X-ray
radiographs as a partially radiolucent implant material.6,7 Based on these desirable
properties, in addition to the aforementioned high strength and fracture toughness, Si 3N4
is used clinically as spinal fusion implants and it is being developed for other biomedical
applications such as bearings in hip and knee joint arthroplasty. 8−10
Near net shape fabrication of Si3N4 materials with the requisite geometry (shape)
and architecture is particularly desirable for custom orthopedic applications but it is also
relevant to other applications, such as high-temperature mechanical engineering
applications. As Si3N4 has a high hardness, post-fabrication machining of the dense
material to achieve the desired complexity in shape and architecture can be costly. In
particular, biomedical implants are often required to have a complex shape to fit into
existing bone defects or unusual patient anatomy and an architecture that is dense, porous
or has a graded porosity, depending on the specific application. For example, some
implants for spinal repair should have a dense Si 3N4 phase to provide the requisite
strength and a porous internal architecture for bone infiltration and integration.
Conventional forming methods such as injection molding, 11,12 slip casting13,14 and
gelcasting15,16 have been used for near net shape fabrication of Si 3N4 ceramics with
simple and complex shapes. However, they are limited in their ability to produce
architectures with a controlled spatial distribution of porosity and the requisite pore size
to facilitate integration of the implants with host bone. In comparison, it has been well
demonstrated that additive manufacturing techniques, sometimes referred to as threedimensional (3D) printing, can provide unprecedented control of the shape and internal
architecture (or microstructure) of ceramic green parts.
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Robocasting is a colloidal-based additive manufacturing method based on
computer-controlled layer-by-layer deposition of a highly concentrated suspension (slurry
or paste) through a nozzle of diameter ∼100 μm to 1 mm.17,18 Robocasting has been used
to form green parts of structural ceramics such as alumina18,19 and silicon carbide19,20,
bioceramics such as hydroxyapatite and beta-tricalcium phosphate 21−23 and bioactive
glass.24−26 Robocasting has also been used to form Si3N4 parts from aqueous slurries
composed of high solids loading (52 vol. % Si 3N4 particles of size 0.77 μm), low
concentration of an anionic polyelectrolyte (1 wt. % Darvan 821A) and a flocculating
agent (0.4 wt. % aluminum nitrate) at pH 7.8 to 8.5.27 Sintering produced a linear
shrinkage of 16% and a final density of 3.21 g/cm 3 which was ∼99% of the theoretical
density, while four-point bending tests of the sintered material showed a flexural strength
of 737 ± 38 MPa.
The objectives of the present study were two-fold. One objective was to develop a
paste formulation for continuous and reproducible robocasting of Si 3N4 parts from a
commonly-used commercial powder (SN-E10; UBE Industries, Japan). Because of its
fine particle size, this powder is known to have attractive sintering characteristics but
difficulties have been reported in dispersing it in aqueous media to high solids loading. 28
The second objective was to create Si3N4 parts with different shape and architecture by
robocasting. The green parts were dried, debinded, fired using a combined sintering and
hot isostatic pressing route, and characterized to evaluate their macrostructure,
microstructure and mechanical properties.
Experimental procedure
Starting powders
The Si3N4 powder (SN-E10; UBE Industries, Tokyo, Japan) used in this study had
an average particle size (D50) of 0.70 μm, a surface area of 9 to 13 m 2/g and α phase
content of > 95% according to the manufacturer’s specifications. The sintering additives
that would lead to the formation of a liquid phase to aid densification were 6.0 wt. %
Y2O3 (D50 = 0.5 μm; purity 98.9%; H. C. Starck, Germany) and 4.0 wt. % Al 2O3 (D50 =
0.3 μm; purity = 99.0%; Baikowski Malakoff, USA) which are a commonly-used
formulation in the production of Si 3N4 materials. In addition, 0.75 wt. % TiO2 (D50 <0.9
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μm; purity 99.8%; Spectrum Chemical, USA) was used as a colorant. The starting
mixture composed of Si3N4 powder, sintering additives and colorant were mixed in a Vblender and provided by a manufacturer of Si 3N4 orthopedic implants (Amedica Corp.,
Salt Lake City, UT).
The particle size distribution of the Si 3N4 powder (without additives) was checked
using a particle size analyzer (S3500; Microtrac, Largo, FL). Dilute suspensions
composed of 0.002 vol. % Si 3N4 particles were used in measuring the zeta potential as a
function of pH using a Zetasizer Nano ZS90 machine (Malvern Instruments Ltd.,
Malvern, UK).
Preparation of suspensions and viscosity measurements
Based on the zeta potential data for the Si 3N4 powder, a cationic polyelectrolyte,
polyethylenimine (PEI) (Aldrich Chemical Co., Milwaukee, WI), was used as a
dispersant−binder system. PEI is effectively neutral at pH values above ∼10 and
develops an increasing positive charge as the pH decreases below this value due to
adsorption of H+ ions, with the amine groups becoming ∼50% protonated at pH of 5 to
6.29 The optimal amount of PEI was assessed from measurements of the viscosity versus
shear strain rate for Si3N4 suspensions containing varying amounts of PEI (as described
below).
The powder mixture, composed of Si3N4 powder and sintering additives (Y2O3 +
Al2O3), referred to simply as Si3N4 powder, was sieved through a 100 mesh nylon sieve
to remove large agglomerates. Suspensions were prepared for use in rheological
measurements by adding the Si3N4 powder to a solution of PEI in deionized water,
followed by mixing in a planetary centrifugal mixer (ARE-310; THINKY, Laguna Hills,
CA). Suspensions composed of 20 vol. % Si 3N4 powder and varying amounts of PEI (0 to
8 wt. % based on the weight of the Si3N4 powder) composed of a high molecular weight
PEI (designated H-PEI; molecular weight Mw= 25,000 Da), a low molecular weight PEI
(L-PEI; Mw = 2,000 Da) or a combination of H-PEI and L-PEI were studied. The
viscosity of the suspensions was measured at room temperature using a controlled-rate
rotational viscometer (Haake Viscotester E; Haake Inc., Paramus, NJ) with a small
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sample adaptor. Measurements were performed with TR series spindles, using 8 to13 ml
of suspension. The shear stress was measured as a function of the shear rate.
Paste preparation for robocasting
The as-received Si3N4 powder (with sintering additives), sieved through a 100mesh sieve to remove large agglomerates, was added to a solution composed of deionized
water and the requisite amount of PEI, and the system was mixed using a planetary
centrifugal mixer (ARE-310; THINKY). Based on the aforementioned viscosity
measurements, a combination of 4.0 wt. % L-PEI and 4.0 wt. % H-PEI was used. The
powder was added to the solution in steps and mixed for 1 min after each step. Then
hydroxypropyl methyl cellulose (Methocel F4M; Mw = 3500 Da; Dow Chemical Co.,
Midland, MI), abbreviated HPMC, was added to the slurry and the system was mixed in
the planetary mixer for 1 min. The HPMC was used as a viscosifying agent to modify the
rheology of the paste.20 Pastes containing varying amounts of HPMC were tested to
determine the optimal amount required to achieve continuous robocasting of green parts
without any visible flaws. The composition of the paste used for robocasting the Si 3N4
parts in this study is given in Table I.
Robocasting of silicon nitride
Green parts were formed using a robotic deposition apparatus (3D Inks; Stillwater,
OK). The three-axis motion of the x, y and z stages was independently controlled by a
computer-aided program (RoboCAD 3.0) that allowed for layer-by-layer deposition of
3D architectures. The paste was contained in a 3 ml syringe and deposited through a
tapered stainless steel nozzle (inner diameter = 410 μm) held in a plastic housing (EFD
precision tips, East Providence, RI). A constant pressure was applied to extrude the paste
through the nozzle at a volumetric flow rate required to maintain a constant xy table
speed of 10 mm/s.
The center-to-center distance between the extruded filaments was varied to
achieve two different architectures. A center-to-center distance of 910 μm was used to
form a porous grid-like architecture composed of filaments arranged at right angles in
adjacent layers and square-shaped pores in the plane of deposition. In comparison, a
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center-to-center distance of 410 μm was used to form a grid-like architecture composed
of touching filaments in the plane of deposition. This architecture is referred to as a “solid”
architecture to distinguish it from the porous grid-like architecture. For each architecture,
green parts were formed with the external geometry of a cube (∼10 mm in length) or a
beam (32 mm × 6 mm × 4 mm). The green parts were dried for 24 h at room temperature,
followed by 24 h at 70 °C.
Binder removal and firing
Thermogravimetric analysis (TGA) was performed to determine the binder
burnout profile of the processing additives alone (L-PEI, H-PEI and HPMC) and the
Si3N4 green parts. A mass of 10 mg was heated in air at 5 °C/min to 600 ℃ using a
thermal analysis instrument (STA 409C; Netsch, Selb, Germany). Then the weight loss
curve was used to develop a heating schedule for the dried parts. Binder burnout was
performed by heating the green parts in air at 2 °C/min to 600 ℃, with a hold of 2 h at
300 °C and at 600°C. The debinded parts were densified by a combination of sintering
and hot isostatic pressing (referred to as sinter/HIP) according to a schedule previously
developed at Amedica Corporation. Sintering was performed for 2 h at ∼1700 ℃ in an N2
atmosphere. Then the sintered samples were further treated by hot isostatic pressing for 2
h at ∼1700 ℃ and N2 gas pressure of ∼200 MPa.
Characterization of green and fabricated Si3N4 parts
The density of the as-fabricated parts was measured using the Archimedes
technique according to ASTM C373-88. The linear shrinkage in the sinter/HIP process
was determined from the dimensions of the dried and final parts. Field-emission scanning
electron microscope (SEM) (S-4700; Hitachi, Tokyo, Japan) was used to examine the
microstructure of the debinded and final parts. Fractured and polished cross sections of
the samples were coated with Au/Pd and examined at an accelerating voltage of 15 kV
and a working distance of 12 mm.
As-fabricated parts with the shape of beams (23 × 4.3 ×2.8 mm) were tested in
four-point bending according to ASTM C1674-11 to determine their flexural strength.
Testing was performed at a crosshead speed of 0.2 mm/min in an Instron testing machine
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(Model 5881; Norwood, MA) using a fully articulated fixture (outer span = 20 mm; inner
span = 10 mm). The flexural strength was determined using the equation
=

(1)

where P is the applied load, L is the outer span, b is the sample width and d is the
thickness of the sample. Six samples in each group were tested and the flexural strength
was determined as an average ± standard deviation.
Results
Characteristics of slurries and green parts
Figure 1 shows the particle size distribution and the zeta potential vs. pH for the
as-received Si3N4 powder (without sintering additives). The average particle size D50 =
0.7 μm is consistent with the manufacturer’s specifications. The zeta potential curve and
the isoelectric point (IEP = 6.2) of the Si 3N4 powder are consistent with results in the
literature for Si3N4 powder with the same manufacturer’s designation. 30 Although the IEP
of the sintering additives was not measured, several studies have reported the IEP of high
purity Al2O3 in the range 8 to 9 and Y2O3 in the range 8.5 to 9.5. As these are almost
stoichiometric oxides, the IEPs of high purity Al 2O3 and Y2O3 are not expected to deviate
from these narrow ranges.
Addition of PEI (4.0 wt. % L-PEI + 4.0 wt. % H-PEI based on the mass of Si 3N4
powder) to deionized water raised its pH to 11.5. Addition of 20 vol. % Si 3N4 powder
(with Y2O3 + Al2O3 sintering additives) to the PEI solution produced little change in the
pH (to 11.4), indicating that the dispersion of the Si 3N4 particles was dominated by the
adsorbed PEI. Figure 2a shows the effect of the amount of H-PEI on the viscosity and
rheological behavior of 20 vol. % Si3N4 suspensions. The viscosity decreased and the
rheological behavior changed from shear thinning to essentially Newtonian as the amount
of H-PEI increased from 0 to 4 wt. %. Increasing the amount of H-PEI to 8 wt. % showed
little further change in viscosity or rheological behavior. The effect of a combination of
H-PEI and L-PEI on the viscosity and rheological behavior of 20 vol. % Si 3N4
suspensions is shown in Figure 2b. The use of 8 wt. % of L-PEI alone did not produce a
marked difference in viscosity and rheological behavior when compared to the
suspension without PEI, indicating that this amount of L-PEI was insufficient to provide
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good dispersion of the particles. In comparison, a combination of 4.0 wt. % L-PEI + 4.0
wt. % H-PEI resulted in a reduction in the viscosity and a near Newtonian rheological
response which was almost identical to the use of 8.0 wt. % H-PEI.
A combination of 4.0 wt. % H-PEI + 4.0 wt. % L-PEI was used for robocasting
because it allowed the incorporation of a slightly higher volume fraction of Si 3N4
particles into the paste when compared to slurries with 8.0 wt. % H-PEI. These pastes
were extrudable but the filaments in the porous grid-like architecture showed some
deformation while the ability to continuously form green parts without flaws was limited.
HPMC additions below 1.0 wt. % (based on the weight of Si 3N4) did not adequately
improve the forming process whereas HPMC additions greater than 2.5 wt. % required a
reduction in the solids content for successful robocasting. The optimal amount of HPMC
used in the slurries was ∼1.5 wt. %.
Figure 3 shows examples of green parts formed by robocasting. Two different
shapes were formed, a cube and a beam, based on the geometry required for mechanical
testing in compression and flexure. For each geometry, parts were created with a porous
grid-like architecture and a solid architecture. All of the green parts showed a uniform
shape and architecture and there was no observable deformation of the individual
filaments in the structures.
Debinding of green parts
Figure 4 shows TGA curves for the binder system used in this study (without the
Si3N4 powder) and for filaments formed by robocasting which were composed of the
same binder system with the Si3N4 powder. The samples were dried prior to TGA. The
curve for the binder system without Si3N4 powder can be divided into three regions. The
first region showed a gradual weight loss between ∼100 °C and ∼300 °C in which ∼20
wt. % of the binder was removed. The second region between ∼300 °C and ∼400 °C
showed a much steeper weight loss, with ∼40 to 50 wt. % of the binder being removed.
In the third region (above ∼400 °C), the weight loss curve decreased more slowly and not
all of the binder was removed at the heating rate used (5 °C/min) when the experiment
was terminated at 600 °C.
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The binder burnout curve for the filament composed of the Si 3N4 powder and the
binder system can also be divided into three regions but they were less distinct. The curve
showed a more gradual decrease with temperature over the entire range (room
temperature to 600 °C). Although the weight loss curve showed the steepest drop
between 300 °C and 400 °C, it was not as distinctive as in Fig. 4a. It appeared that the
Si3N4 powder and sintering additives (Y2O3 + Al2O3) might be having a catalytic effect
on the binder decomposition, leading to a relatively greater amount of weight loss in the
first region (below ∼300 °C) relative to that in the second region.
SEM images of the surface and fractured cross section of a filament after binder
burnout are shown in Fig. 5 at different magnifications. As might be expected, the surface
morphology was smoother than the fractured cross section (Fig. 5a, b). Higher
magnification images showed a fairly homogeneous particle packing and the absence of
large pores (Fig. 5c, d). At an even higher magnification, SEM images indicated that the
largest pores had a size smaller than 1 to 2 μm (Fig. 5e, f).
Microstructure of fabricated Si3N4 parts
Optical images of the Si3N4 parts after sinter/HIP (Fig. 6) showed no observable
distortion of the external shape of the parts and no observable deformation of the
filaments in the parts with the porous grid-like architecture when compared to the green
parts (Fig. 3). The apparent density of the solid phase in the porous grid-like parts was
3.18 ± 0.01 g/cm3, approximately 99% of the value (∼3.23 g/cm3) reported in the
literature for fully-dense Si3N4 fabricated with the sintering additives used in this study.
The porosity of the open macropores in the porous grid-like parts was 51.5% and 56.5 %,
respectively, for the cube-shaped and beam-shaped samples, and the pore width was
∼350 μm in the plane of deposition. The bulk density of the parts with the solid
architecture was 3.23± 0.02 g/cm3, approximately equal to the density of a fully dense
material. The average of the measured densities for the porous grid-like parts or the solid
parts was not dependent on the geometry of the parts (cube or beam). The linear
shrinkage of the samples after sinter/HIP was 27.8%.
SEM images of the polished cross section (in the z direction) of the cube-shaped
parts with the porous grid-like architecture are shown in Fig. 7a, c. The higher
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magnification image showed few isolated pores of size <1 μm in the sold phase. At
similar magnification, images of cube-shaped samples with the solid architecture showed
a fully dense microstructure (Fig. 7b, d).
SEM images of the surface of the filaments in the as-fabricated Si 3N4 parts with a
porous grid-like architecture (Fig. 8a, b, c) showed a fibrous microstructure of rod-like
grains (diameter 1 to 2 μm). The rod-like grains had a hexagonal cross section typical of
β-Si3N4 and there appeared to be little glass phase (or solidified liquid phase) between
these rod-like grains on the filament surface. Examination of the fractured cross section
on the filaments (Fig. 8d) showed that the rod-like grains were also present within the
filaments, as seen particularly in the areas with more pronounced intergranular fracture.
These fibrous grains within the filaments had a diameter that was approximately the same
as those on the surface but they appeared to be bonded together by the solidified liquid
phase.
Mechanical properties of as-fabricated Si3N4 parts
The compressive strength of the cube-shaped parts was not determined because
the required force was higher than the capacity of the available load cell (10 kN) in the
mechanical testing machine. This means that the compressive strength of the porous gridlike parts (porosity of macropores = 51.5%) was higher than ∼200 MPa. The fully dense
parts with the solid architecture is expected to have a considerably higher compressive
strength. Four-point bending tests of the as-fabricated beams showed a flexural strength
of 552 ± 68 MPa for the solid parts and 89 ± 11 MPa for the porous grid-like parts
(porosity of macropores = 56.5%). SEM images of the fractured surface of the samples
after flexural testing (Fig. 9) showed a combination of intergranular and transgranular
fracture modes. The bottom region of the samples, under tension in the four-point tests,
apparently showed a larger amount of intergranular fracture than the top region (under
compression during the tests). However, there was no marked difference in fracture
morphology between the parts with the solid architecture and the porous grid-like
architecture.
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Discussion
The development of an aqueous paste composed of a fine commercial Si 3N4
powder, commonly-used sintering additives (Y2O3 + Al2O3) and organic processing
additives allowed the continuous and reproducible robocasting of green parts with
different geometry and architecture. A combination of sintering and hot isostatic pressing
(sinter/HIP) resulted in the production of parts without any observable shape deformation
and with an almost fully dense Si3N4 phase composed of rod-like grains. Testing of asfabricated dense parts in four-point bending showed an average flexural strength of 552
MPa. The fabrication process used in the present study could provide a viable
manufacturing strategy for the creation of Si 3N4 implants with complex architectures and
anatomically-relevant shapes for applications in orthopedic surgery.
Paste development and robotic deposition
The structural integrity of green parts created by robocasting is strongly
dependent on the rheological properties of the paste (or slurry) and on the drying of the
deposited layers. In addition to high solids loading, the slurry should have the requisite
rheology to flow through the nozzle but then set rapidly to maintain the desired 3D shape
and architecture. In general, this means that the slurry should show pseudoplastic
behavior with a yield stress that is high enough to prevent deformation of the printed
structure under its own weight.31
Difficulties were encountered in our preliminary robocasting experiments to
continuously extrude filaments from an aqueous paste composed of the Si 3N4 powder, a
commercial anionic polyelectrolyte dispersant, Darvan 821A (a solution of 40 wt. %
ammonium polyacrylate) and a flocculating agent (ammonium nitrate), as reported in a
previous study for a different commercial Si3N4 powder.27 Presumably the negative
surface charge of the Si3N4 particles and the highly negative charge of the anionic
polyelectrolyte at basic pH values (7.8 to 8.5) used in that study inhibited adsorption of
the polyelectrolyte on the particle surface. In general, Si3N4 powders produced by
different manufacturers have different physical characteristics (e.g., surface area) and
surface chemistry which can have a strong effect on colloidal and rheological properties.
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The use of a cationic polyelectrolyte, PEI, in the present study allowed the
development of a paste formulation that provided continuous robocasting of simple and
complex structures without observable flaws. The addition of PEI to deionized water
resulted in an increase in pH of the solution to highly basic values (∼11.4), due to
adsorption of hydrogen (or hydronium) ions.29 At these pH values, the surface of the
Si3N4 particles and the Y2O3 and Al2O3 particles used as sintering aids are negatively
charged. As the surface of the particles and the PEI are oppositely charged, adsorption by
electrostatic attraction is favored.
Lower molecular weight PEI is often better suited for use as a dispersant whereas
higher molecular weight PEI can serve as both a dispersant and an effective binder. 31 The
use of a combination of 4.0 wt. % L-PEI and 4.0 wt. % H-PEI resulted in the formation of
pastes with an optimal combination of viscosity and solids content. However, upon
robocasting, the extruded filaments did not maintain their shape, particularly for articles
having a complex shape or a porous grid-like architecture. The addition of HPMC vastly
improved the ability to form parts continuously without observable flaws. HPMC can act
as a viscosifying agent and its addition presumably altered the rheological response of the
paste, preventing phase separation during extrusion and improving the ability of the asformed structure to maintain its geometry.
Microstructure of debinded and fired parts
In general, the microstructure of the debinded (or green) parts provides a useful
indication of their sinterability. Homogeneous random particle packing and pores of low
coordination number (fine pores) are beneficial for sintering. SEM images of the surface
and cross section of the extruded filaments after debinding (Fig. 5) indicate that these
requirements were achieved to a large extent. Neighboring regions with markedly
different packing density were apparently absent and the largest pores were smaller than
1 to 2 μm.
Based on the formulation given in Table I, the solids content of the paste used for
robocasting was ∼35 vol. %. Because of this low solids content, the parts showed a fairly
large shrinkage of 27.8% during firing (sinter/HIP). However, despite the low solids
content of the paste, the Si3N4 phase in both the macroporous grid-like parts and the solid
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parts reached almost full density during sinter/HIP. In the sinter/HIP route (which avoids
the use of an encapsulating glass or metal can), parts have to be sintered to closed
porosity (total porosity less than 5 to 10%, depending on the particle packing
homogeneity of the green part) for the HIP step to be effective in removing the remaining
porosity. If open pores are present, the high gas pressure used in the HIP step would
prevent them from shrinking. Consequently, despite the low solids content of the paste,
the green parts experienced considerable densification. While the density of the parts was
not measured after the sintering step, it is reasonable to assume that the parts were
sintered to a porosity lower than 5 to 10%.
In addition to the nearly full density of the Si3N4 phase, there was no observable
deformation of the filaments in the macroporous grid-like architecture or the external
geometry of the fired parts (Fig. 3 and Fig. 6). Studies in the ceramic literature show that
some green articles, particularly articles formed from fine particles, can be sintered to
almost full density despite a low particle packing density (<40 to 50%).31 Homogeneous
particle packing and fine pores in the green parts formed by robocasting in this study (Fig.
5) were presumably beneficial for uniform shrinkage and considerable densification
without deformation of the fired parts.
Despite the ability to produce macroporous and solid parts composed of a dense
Si3N4 phase which showed no observable distortion, an increase in the particle packing
density of the green parts (while maintaining the homogeneous packing) would be useful.
A higher particle packing density leads to a reduction in the shrinkage required to achieve
a given density during firing, which is useful for better controlling the dimensions of the
fabricated part, particularly in the production of large parts. This might be achieved by
improved treatment of the starting powder (Si 3N4 and sintering aids) prior to paste
formulation. In the present study, a powder blend formed by mixing the as-received
starting powders was used in the paste formulation. This powder blend was provided by
Amedica Corporation and is typically used to form Si 3N4 green articles by pressing.
Although the powder blend was sieved to remove agglomerates larger than ∼100 μm in
the present study, the use of additional treatments should be studied. The as-received
Si3N4 power should be attrition milled to break up agglomerates. Thereafter, the powder
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should be attrition milled a second time with the sintering aids (Y 2O3 and Al2O3 powders)
to achieve a well-mixed powder free from large agglomerates.
Mechanical properties
Si3N4 can be produced with high flexural strength (>1 GPa) and fracture
toughness of up to ∼10 MPa m1/2 but this requires careful control of the size and amount
of well-dispersed large elongated grains in a fine-grained matrix. 5 The use of β-Si3N4
seed particles and controlled hot pressing conditions have been found to be useful in
achieving a well-controlled grain distribution. Significantly lower flexural strength and
fracture toughness are often obtained when the Si3N4 has an unregulated microstructure
composed of a broad grain distribution. The flexural strength is also dependent on the
present (or absence) of surface flaws. Typically, specimens used in flexural testing have
their surfaces finished with diamond grinding to provide a controlled surface free from
large flaws.
In the present study, the specimens were tested in the as-fabricated state and
without surface grinding. This is because Si 3N4 implants are typically used in the asfabricated state (after sterilization) in spinal fusion applications. The fibrous surface
morphology of the as-fabricated material has also been reported to endow the Si 3N4
implants with antibacterial activity.9 Consequently, the flexural strength of the asfabricated material provides a better approximation to the flexural strength of Si 3N4
constructs that are implanted clinically. When compared to the flexural strength reported
in some studies,5 the lower flexural strength of the solid specimens in the present study
(552 ± 68 MPa) is presumably due to an unregulated grain distribution and a lack of
surface machining. A standard sinter/HIP schedule without seed particles was used. As
the specimens were tested in the as-fabricated state, their surfaces consisted of a random
arrangement of protruding fibrous grains (Fig. 8c). The surface of these as-fabricated
specimens can be approximated to a surface with a distribution of flaw sizes. It is well
known that the strength of brittle materials varies inversely as the square root of the
largest flaw size.
In general, the Si3N4 parts fabricated in the present study have strengths that are
more than adequate for orthopedic applications coupled with a fibrous surface

127
morphology that is reported to be beneficial for antibacterial activity. The compressive
and flexural strengths of human cortical bone are in the range 100 to 150 MPa. The
flexural strength of the solid Si3N4 specimens (552 ± 68 MPa) is considerably higher than
cortical bone. The compressive strength was too high to be measured with the available
testing machine but, like ceramics in general, it is expected to be several times the
flexural strength. Specimens with a porous grid-like architecture (porosity = 56.5%; pore
width ∼350 μm) showed a flexural strength (89 ± 11 MPa) comparable to human cortical
bone. Macroporous Si3N4 implants with a gradient in porosity to mimic human cortical
bone could provide flexural strengths that are higher than the porous grid-like parts
created in the present study in addition to interconnected pores with the requisite size for
bone infiltration.
Conclusions
An aqueous paste composed of Si 3N4, sintering additives and organic processing
additives was developed for continuous robocasting of green parts with different
geometry and architecture. Sintering followed by hot isostatic pressing (sinter/HIP)
produced macroporous parts with a grid-like architecture and solid parts with an almost
full dense Si3N4 phase (density 3.23 ± 0.02 g/cm3) and a microstructure of fibrous grains
typical of in situ toughened Si3N4. Four-point bending tests of as-fabricated solid samples
in the shape of beams showed a flexural strength of 552 ± 68 MPa. Samples with a
macroporous grid-like architecture (porosity = 56.5%; pore width = 350 μm) showed a
flexural strength of 89 ± 11 MPa. Together, the results indicate that robocasting
combined with the sinter/HIP technique could provide a viable approach to create Si 3N4
implants with anatomically relevant shapes and internal architectures for applications in
orthopedic surgery.
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Table I. Composition of slurry used in robocasting of Si3N4
Material

Composition (wt. %)

Si3N4 + Y2O3 + Al2O3

61.8

H-PEI (high molecular wt. PEI)

2.5

L-PEI (low molecular wt. PEI)

2.5

HPMC (hydroxypropyl methyl cellulose)

0.9

Deionized water

32.3

Fig. 1. (a) Particle size distribution and (b) zeta potential vs. pH for as-received Si 3N4
powder (without sintering additives).

Fig. 2. Viscosity vs. shear rate for aqueous suspensions composed of 20 vol. % Si 3N4
particles and varying amounts of (a) high molecular weight polyethylenimine (H-PEI)
and (b) a combination of H-PEI and low molecular weight PEI (L-PEI). The amount of
PEI is expressed as a percentage of the weight of the Si 3N4 powder.
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Fig. 3. Optical photographs of Si3N4 green parts with a porous grid-like architecture or a
solid architecture and with the geometry of a cube or a beam.

Fig. 4. Thermogravimetric analysis (TGA) curves for the binder system alone (4.0 wt. %
H-PEI + 4.0 wt. % L-PEI + 1.5 wt. % HPMC based on the weight of the Si 3N4 particles
used in the robocasting paste) and the paste (binder system plus Si 3N4 powder) used in
the robocasting experiments. The samples were heated in air at 5 °C/min to 600 °C.
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Fig. 5. SEM images of the filaments in debinded parts with a porous grid-like architecture.
The fractured cross section (a, c, e) and surface (b, d, f) of the filaments are shown.

Fig. 6. Optical images of Si3N4 parts after sintering and hot isostatic pressing (sinter/HIP).
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Fig. 7. SEM images of the polished cross-section of fired Si 3N4 parts with a porous gridlike architecture (a, c) and with a solid architecture (b, d) at different magnifications.

Fig. 8. SEM images of a fired Si3N4 part with a porous grid-like architecture showing (a)
the filaments in the part, (b, c) the surface of a filament at lower and higher magnification,
and (d) the fractured cross section of a filament.
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Fig. 9. SEM images of the fractured surface of fired parts with a solid architecture (a, b)
and a porous grid-like architecture (c, d) after failure in four-point bending.
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